日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  22(2)

日本癌治療学会

国立国会図書館雑誌記事索引 1 (1) 1966.03~;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行

「国立国会図書館デジタルコレクション(雑誌)」より

[目次]

  • Presidential Lecture Diagnosis and Treatment of Bone Tumors in Japan--The History and View / I.Maeyama / p131~132
  • Special Lecture 1. Induction of Differentiation of Tumor Cells and an Approach to Therapy of Tumors / M.Hozumi / p133~133
  • Special Lecture 2. Prospect of Immunological Approaches to Diagnosis and Therapy of Cancer, Especially with Monoclonal Antibodies and Recombinant Cytokines / T.Tokunaga / p134~134
  • Special Lecture 3-1. Improving Cancer Treatment From the Standpoint of Basic Cancer Research / S.Takayama / p135~135
  • Special Lecture 3-2. Consideration on Appropriate Measures to Elevate the Cure Rate of Gastric Cancer / K.Inokuchi / p136~136
  • Special Lecture 4. The Role and Progress of Plastic Surgery in the Treatment of Cancers / K.Harii / p137~137
  • Special Lecture 5. Present Situation on Nationwide Registration of Gastric Cancer / K.Miwa / p138~140
  • Invitational Lecture 1. The Use of Massive Osteoarticular and Intercalary Allografts in Limb Preservation in Patients with Bone Tumors / H.J.Mankin / p141~141
  • Invitational Lecture 2. Not Received / /
  • Invitational Lecture 3. Surgical Adjuvant Therapy of Colorectal Cancer,Trials,Errors and Glimmers of Hope / C.G.Moertel / p142~154
  • Symposium 1 Limb Salvage Treatment for Osteosarcoma / / p155~163
  • 1. Rationale of Preoperative Chemotherapy for Osteosarcoma / K.Furuse / p155~155
  • 2. Limb-sparing Surgery Combined with Pre-operative Intra-arterial Infusion of Anti-cancer Agents in the Treatment of Osteosarcoma / S.Takeuchi et al. / p156~156
  • 3. Limb Salvage for Osteosarcoma Significance of Preoperative Isolation Perfusion Chemotherapy / S.Takeyama et al. / p157~157
  • 4. The Role of Fast Neutron Radiotherapy in the Treatment of Osteosarcoma / N.Takada / p158~158
  • 5. Value of Limb Saving Operation in Treatment of Osteosarcoma / N.Kawaguchi et al. / p159~159
  • 6. Application of Biomaterials for the Limb Saving Procedure of Ostesarcoma / Y.Kotoura et al. / p160~160
  • 7. Significancy of Surgical Adjuvant Chemotherapy of Osteosarcoma / S.Yamawaki et al. / p161~161
  • 1(1). Autologous Bone Marrow Transplantation for Osteosarcoma / M.Ohira et al. / p162~162
  • 1(2). Functional Evaluation of Preserved Limb Following Resection of Malignant Bone Tumors Including Osteosarcoma / K.Tomita / p163~163
  • Symposium 2 Development of Cancer Surgery by New Medical Instruments / / p164~174
  • 1. Surgery for Metastatic Brain Tumors with New Surgical Instruments / K.Nomura et al. / p164~165
  • 2. Examination and Comparison between the New Therapeutic Methods Developed by Modern Engineering / A.Hohki / p166~166
  • 3. Qualitative Improvement of Surgical Treatment for Lung Cancer Using Laser / H.Kato et al. / p167~167
  • 4. Efficacy and Limitations of the Laser Surgery for the Malignant Tumor / F.Sano et al. / p168~168
  • 5. Intraoperative Ultrasound Guided Hepatic Resection / M.Makuuchi et al. / p169~169
  • 6. Preparation of Antithrombogenic Bypass-Catheter of the Portal Vein and Its Application to the Extended Radical Operation Accompanied by Portal Vein Resection for Pancreatic Cancer / A.Nakao et al. / p170~170
  • 7. New Operative Technique to Resect Cardiac Cancers Accompanying Lower Mediastinal Lymph Nodes Dissection through Abdomino-phrenotomy without Thoracotomy Using Improved Hook Suspender and Autosuture Instrument / K.Yoshino et al. / p171~171
  • 8. Usage of CUSA(Cavitron Ultrasonic Surgical Aspirator)in the Radical Operation for Cervical Carcinomas of the Uterus / Y.Morishita et al. / p172~172
  • 9. Laser Vaporization and Incisional Conization as a Conservative Therapy for a Cervical Neoplasia / K.Wakita et al. / p173~173
  • 10. Clinical Significance of Combined Use Radiation Therapy and Hyperthermia / T.Matsuda et al. / p174~174
  • Symposium 3 New Device of Irradiation Method Using Conventional Radiotherapy Equipments / / p175~182
  • 1. CT and MRI in Radiotherapy / G.Irie et al. / p175~175
  • 2. Brachytherapy for the Cancer / M.Nishio / p176~176
  • 3. Combination of Radiation and Drug Therapy / K.Morita / p177~177
  • 4-(1). Total Body Irradiation as a Method of Preparation for Bone Marrow Transplantation in the Treatment of Leukemia / T.Inoue / p178~178
  • 4-(2). The Effect of Low Dose of Total Body Irradiation on Tumor Control / K.Sakamoto et al. / p179~179
  • 5-(1). Preoperative Radiotherapy on Brain Tumors / T.Kondo / p180~180
  • 5-(2). Preoperative Radiotherapy Part II Adenocarcinoma of the Stomach and Breast / S.Kamimura / p181~181
  • 6. Intraoperative Radiotherapy / K.Hata / p182~182
  • Symposium 4 Diagnosis and Treatment of Malignant Soft Tissue Tumors / / p183~189
  • 1. Pathologic Diagnosis of Malignant Soft Tissue Tumors--General Considerations / M.Enjoji / p183~183
  • 2. An Ultrastructural Approach of Malignant Soft Tissue Tumors / M.Tsuneyoshi / p184~184
  • 3. Pathological Diagnosis--Special Staining / M.Mukai / p185~185
  • 4. Surgical Treatment for Soft Tissue Sarcoma / K.Amino et al. / p186~186
  • 5. Analysis of Liposarcoma / Y.Ubayama / p187~187
  • 6. Treatment of Rhabdomyosarcoma / Y.Beppu et al. / p188~188
  • 7. Treatment of Malignant Fibrous Histiocytoma (MFH) / N.Shinohara et al. / p189~189
  • Symposium 5 New Approaches in Cancer Chemotherapy / / p190~197
  • I-1. Trials of New Methods for Cancer Chemotherapy--Human Tumor Clonogenic Assay / N.Saijo et al. / p190~190
  • I-2. Subrenal Capsule Assay / K.Inoue / p191~191
  • I-3. Biochemical Nature and Therapeutic Approaches against Drugresistant Tumors / T.Tsuruo / p192~192
  • II-1. Biochemical Modulation with Sequential Methotrexate-5-Fluorouracil Treatment / K.Ota / p193~193
  • II-2. Application of Bone Marrow Transplantation to Leukemia Therapy--From the Registry of BMT Study Group Japan / T.Masaoka / p194~194
  • II-3. Chemoembolization / H.Nakamura / p195~195
  • II-4. Chemotherapy and Laparotomy in the Management of Ovarian Malignancies: Evaluation of Second-look Operation / M.Yakushiji / p196~196
  • II-5. Salvage Surgery Following Chemotherapy in Advanced Testicular Tumors / T.Kotake et al. / p197~197
  • Symposium 6 Bone Metastases of Various Organ Malignancies / / p198~207
  • I. Histopathology and Clinicopathology of Metastatic Bone Tumors / S.Moriwaki / p198~198
  • II-1. Bone Metastasis in Advanced Breast Cancer / I.Adachi et al. / p199~199
  • II-2. Recent Status of the Diagnosis and Treatment of Bone Metastasis in Patients with Advanced Lung Cancer / K.Eguchi et al. / p200~200
  • II-3. Carcinoma of the Prostate / T.Kawai / p201~201
  • II-4. Renal Cell Carcinoma / K.Matsumoto / p202~202
  • II-5. Clinicopathological Study of Bone Metastasis of Gastric Cancer and Its Therapy / H.Nishidoi et al. / p203~203
  • II-6. Bone Metastasis of Malignant Solid Tumors in Childhood / N.Taguchi / p204~204
  • III-1. Diagnosis and Treatment for Metastatic Bone Cancer of the Extremity / H.Fukuma et al. / p205~205
  • III-2. Diagnosis and Treatment of Secondary Spine Tumors / S.Inoue / p206~206
  • III-3. Radiation Therapy and Diagnosis of Bone Metastasis / T.Mamiya et al. / p207~207
  • Workshop 1. The Effect of Cycrophosphamide for Lymphocyte Subsets Using Two Color Analysis of Monoclonal Antibody by Flow Cytometry / H.Yamagishi et al. / p208~208
  • Workshop 2.Pharmacokinetics of Cisplatin in Children with Malignant Solid Tumors / K.Sue et al. / p208~208
  • Workshop 3.Studies on Pharmacokinetics of CDDP in Gynecological Malignant Diseases / M.Murae et al. / p208~208
  • Workshop 4.Therapeutic Efficacy and Pharmacokinetics of Cisplatin in Patients with Non-Small Cell Lung Cancer / Y.Kusunoki et al. / p209~209
  • Workshop 5.Continuous Infusion Cisplatin for Neuroblastoma in Childhood / T.Hattori et al. / p209~209
  • Workshop 6.The Sequential Combination Chemotherapies Based on Synchronization Theory,for Urogenital Cancers / Y.Ishibashi et al. / p209~209
  • Workshop 7.Intraperitoneal (Ip) Cisplatinum (CDDP) Chemotherapy in Patients with Ovarian Cancer -Report III AUC of Free Platinum (Pt) and Peritoneal Clearance / M.Oku et al. / p210~210
  • Workshop 8.Primary Chemotherapy of Cis-Platinum for Cervical Cancer by Intraarterial Infusion / T.Izutsu et al. / p210~210
  • Workshop 9.Selective Intraarterial Infusion Chemotherapy of CDDP on Cervical Cancer / H.Sato er al. / p210~210
  • Workshop 10.Balloon Occluded Arterial Infusion Chemotherapy with CDDP for the Treatment of Malignant Bone and Soft Tissue Tumors / Y.Tomizawa et al. / p211~211
  • Workshop 11.A Study of Two Ways of Administration of CDDP Powder to Patients with Hepatocellular Carcinoma / J.Shindo et al. / p211~211
  • Workshop 12.Trans-arterial Infusion Chemotherapy Using Multi-anticancer Agents Suspended in Lipiodol / H.Taniguchi et al. / p211~211
  • Workshop 13.Pharmacokinetic Study of Two Route Chemotherapy / R.Abe et al. / p212~212
  • Workshop 14.Pharmacokinetics of CISPLATIN with STS Administration / S.Matsumoto et al. / p212~212
  • Workshop 15.The Side Effects Following Intraperitoneal (IP) Administration of DDP with or without STS with Special Reference to Serum and Ascitic Levels of the Free CDDP / K.Takizawa et al. / p212~212
  • Workshop 16."Two Channel Chemotherapy"for Malignant Pleural Effusion / K.Kitajima et al. / p213~213
  • Workshop 17.Anti-tumor Activity and Side Effect of IpTCC in the Treatment of Ovarian Carcinoma / N.Kawai et al. / p213~213
  • Workshop 18.An Analytical Study on the Mechanism of Coenzyme Q₁₀ Enhancement of the Effect of Adriamycin in Cultured Mouse Sarcoma Cells / K.Toda et al. / p213~213
  • Workshop 19.The Experimental Study for Continuous Hepatic Arterial or Portal Infusion Therapy Using Adriamycin against Metastatic Liver Tumor / T.Mori et al. / p214~214
  • Workshop 20.An Evaluation of the Plasma Concentration of Anticancer Agents Following One Shot Therapy and Transcatheter Arterial Embolization (TAE) Therapy in Hepatocellular Carcinoma / Y.Aoki et al. / p214~214
  • Workshop 21.A Study on Effect of Calcium Antagonist (Verapamil)--Concentration in Blood, Side Effect and Anticancerous Effect in Its Combined Use with Adriamycin, Vincristine and Vinblastin / S.Iwabuchi et al. / p214~214
  • Workshop 22.Intravesical Chemotherapy for Bladder Cancer by Adriamycin Adhering to Bladder Mucosa / K.Ueda et al. / p215~215
  • Workshop 23.Pharmacokinetics of 5-FU in Various Administration Methods / H.Fujita et al. / p215~215
  • Workshop 24.Not Received / /
  • Workshop 25.Characteristic Pharmacodynamics of 1-Hexylcarbamoyl-5-fluorouracil (HCFU) Metabolism after Oral Administration in Cirrhotics with Hepatocellular Carcinoma / K.Takenaka et al. / p215~215
  • Workshop 26.Clinicopathological Study of Gastric Cancer after Neoadjuvant Sequential Therapy of MTX-5FU / S.Minaguchi et al. / p216~216
  • Workshop 27.The Significance of the Presensitization before Intratumor Injection of OK-432 in Gastric Cancer Patients / A.Gochi et al. / p216~216
  • Workshop 28.Intraperitoneal Administration of β-interferon in Gastric Cancer Patients with Peritoneal Recurrence (Values of Ascites and Serum IFN Levels and Its Antitumor Effect) / T.Notsuka et al. / p216~216
  • Workshop 29.Intracavitary Administration of Recombinant Interferon-β in Cancer Patients with Malignant Effusion / M.Tanada et al. / p217~217
  • Workshop 30.In vivo, Antitumor Effect of Receptor Mediated Agent,Neocarzinostatin-Transferrin Conjugate against Heterotransplanted Human Colon Carcinoma in Nude Mice / J.Kato et al. / p217~217
  • Workshop 31.Pharmacological Study of Cisplatin and Carboplatin:A New Method for Evaluation of Analogues by Bioassay Using Clonogenic System / Y.Sasaki et al. / p217~217
  • Workshop 32.A New Trial of Treatment of Gastric Cancer with Aclarubicin / D.Kagawa et al. / p218~218
  • Workshop 33.K-18, Conjugate of Human IgG and Melphalane Accumulates Selectively into the Tumor / K.Ohgaki et al. / p218~218
  • Workshop 34.Chemotherapy for Carcinomatous Peritonitis and Pleuritis Using Anticancer Agents Adsorbed on Activated Carbon Particles / A.Hagiwara et al. / p218~218
  • Workshop 35.Adjuvant Chemotherapy with Prolonged Releasing Microcapsule Encapsulated Anticancer Drug / H.Mori et al. / p219~219
  • Workshop 36.Intraarterial Infusion Therapy Using Polysaccharide Solution as a Carrier of Anticancer Drugs / T.Shimizu et al. / p219~219
  • Workshop 37.Hepatic Arterial Infusion Chemotherapy of FAM in Metastatic Liver Cancer(2nd Report) / Y.Arai et al. / p219~219
  • Workshop 38.Clinical Trial of Degradable Starch Microspheres (DSM) in the Treatment of Hepatomas by Intra-arterial Infusion of Anticancer Drugs / T.Yamada et al. / p220~220
  • Workshop 39.Intra Arterial Superselective ACNU Administration for Malignant Glioma / Y.Tokuriki et al. / p220~220
  • Workshop 40.Study Intra Arterial Chemoembolization of Advanced Ovarian Cancer / J.Kumagai et al. / p220~220
  • Workshop 41.Pharmacokinetic Study of Anticancer Drug under Induced Hypertension Chemotherapy / M.Okamoto et al. / p221~221
  • Workshop 42.The Intracisternal Injection of ACNU for Malignant Leptomeningeal Tumor / S.Koh et al. / p221~221
  • Workshop 43.The Effect of Neoadjuvant Chemotherapy for Malignant Bone and Soft Tissue Tumors / H.Kawano et al. / p221~221
  • Workshop 44.Chemical Lymph Node Dissection for Stomach Cancer / O.Kobayashi et al. / p222~222
  • Workshop 45.Investigations on Newly Designed Chemotherapy According to Pharmacokinetics of Anticancer Agent for Cancer of the Esophagus / T.Uchiyama et al. / p222~222
  • Workshop 46.Not Received / /
  • Workshop 47.Mass Screenings of Cervical Cancer by Practitioner System in Fukuoka Prefecture / S.Yoh et al. / p222~222
  • Workshop 48.Population Screening of Cervical Cancer on 3,000 Cases Using Computerreized Flow Cytometry / M.Sone et al. / p223~223
  • Workshop 49.The Present Condition and the Problem of Mass Screening for Carcinoma of the Cervix / H.Iwasaki et al. / p223~223
  • Workshop 50.The Point at Issue of Mass Screening for Uterine Cervical Cancer--Assessment of the Setting Up the"Model Area" / K.Takahashi et al. / p223~223
  • Workshop 51.Studies on Mass Screening for Cervical Cancer in Shiga Prefecture / J.Matsumoto et al. / p224~224
  • Workshop 52.The Field Trial for Early Detection of Ovarian Cancer Patients / H.Kobayashi et al. / p224~224
  • Workshop 53.Not Received / /
  • Workshop 54.Present Situation and Problems of Mass Examination--With Special Reference to Evaluation of Overlooked Cases and Self-examination / S.Ito et al. / p224~224
  • Workshop 55.The Significance of Cytologic Examination of Nipple Discharge on Detection or Breast Cancer by Mass Screening / M.Kimura et al. / p225~225
  • Workshop 56.Mass Screening of Breast Cancer in Yokohama City / H.Gotoh et al. / p225~225
  • Workshop 57.Mass Screening of Breast Cancer in Kanagawa Prefecture(7th Report) / Y.Takasu et al. / p225~225
  • Workshop 58.Mass Screening for Breast Cancer in Kyoto City--The Role of Palpitation and Ultra Sonography / K.Sawai et al. / p226~226
  • Workshop 59.Concurrent Mass Screening for Breast and Thyroid Cancer in Gunma Prefecture / T.Ishida et al. / p226~226
  • Workshop 60.The Present Situation and Problems of Mass Screening Systems of GI Tract in Japan / T.Yamada et al. / p226~226
  • Workshop 61.General Mass Screening for Digestive Disease with Upper GI X-ray,Occult Blood Test,Ultrasonography and Blood Test / Y.Saito et al. / p227~227
  • Workshop 62.Present Status and Problems in Mass Screening of Hepatic Disease / T.Watayo et al. / p227~227
  • Workshop 63.The Useful Method of Us Mass-Screening to Detect Hepatocellular Carcinoma(HCC) / T.Sakai et al. / p227~227
  • Workshop 64.Problems in Sputum Cytology Mass Survey for Lung Cancer Detection / C.Konaka et al. / p228~228
  • Workshop 65.Results and Problems of Lung Cancer Mass Survey in Okayama / T.Tamura et al. / p228~228
  • Workshop 66.Occurrence and Counterplan of Prostatic Diseases in Keihoku-cho Town / M.Nakao et al. / p228~228
  • Workshop 67.Mass Screening of the Prostate by Rectal Examination,Serum Acid Phosphatase and Transrectal Ultrasonography / S.Ishikawa et al. / p229~229
  • Workshop 68.Cancer Control Programs in Miyagi Prefecture--The Actual Condition and Future Approach / S.Hisamichi et al. / p229~229
  • Workshop 69."Field Carcinogenesis"in Patients with Head and Neck Squamous Cell Carcinoma / H.Shibuya et al. / p229~229
  • Workshop 70.The Role of Ratio of Androgen to Corticosteroid in the Environmental Factor of Breast Cancer / Y.Nakamura et al. / p230~230
  • Workshop 71.Obesity and Sex Hormones as a Risk Factor of Breast Cancer / Y.Murayama et al. / p230~230
  • Workshop 72.Malignant Potential of Gastric Cancer as Function of Sex and Age / H.Furukawa et al. / p230~230
  • Workshop 73.Immunological Activity of Peripheral Blood Lymphocytes(PBL)and Regional Lymphnode Lymphocytes(LNL)of Cancer Patients / W.Ugajin et al. / p231~231
  • Workshop 74.Adoptive Immunotherapy(AIT)Using Regional Lymph Node Lymphocytes Cultured with IL-2 / T.Okino et al. / p231~231
  • Workshop 75.Immunohistochemical Study of Regional Lymph Nodes in Gastric and Breast Cancers / S.Amano et al. / p231~231
  • Workshop 76.Immunocompetence in Regional Lymph Nodes of Esophapeal Cancer / M.Oka et al. / p232~232
  • Workshop 77.Host Immune Responses in Regional Lymph Nodes of Gastric Cancer Patients / T.Inagaki et al. / p232~232
  • Workshop 78.Analysis of Regional Lymphnode T-Lymphocyte Subsets in Patients with Gastric Cancer / S.Togo et al. / p232~232
  • Workshop 79.Cell-mediated Cytotoxic Activity of Regional Lymph Node Cells(LNC)from Patients with Gastric Carcinoma / F.Koba et al. / p233~233
  • Workshop 80.Augmentation of Cytotoxicity of Regional Lymph Node Lymphocytes of Gastric Cancer by Intratumoral Injection of Recombinant Interleukin 2 / G.Kobayashi et al. / p233~233
  • Workshop 81.Effects of Oral OK432 in Gastric Cancer Patients / Y.Nio et al. / p233~233
  • Workshop 82.Effects of the Intratumoral Administration of OK-432 through an Endoscope on the Immunological Response of Regional Lymphnodes in Early Gastric Cancer / T.Katsube et al. / p234~234
  • Workshop 83.Study of the Cellular Immunological Competence of Regional Lymphnodes in Colon Cancer / N.Matsumoto et al. / p234~234
  • Workshop 84.Distribution of Natural Killer Cell in Regional Lymphnode of Colorectal Cancer / W.Adachi et al. / p234~234
  • Workshop 85.Cytotoxic Activity of IL-2 Stimulated Regional Lymphnode Lymphocytes against Autologous Lung Cancer Cells / H.Kimura et al. / p235~235
  • Workshop 86.Immunomorphologic Changes of Regional Lymph Nodes in Uterine Cervical Cancer / M.Kinugasa et al. / p235~235
  • Workshop 87.Immunological Competance of Regional Lymph Nodes in Breast Cancer Patients / T.Aono et al. / p235~235
  • Workshop 88.Sinus Histiocytosis of Regional Lymph Nodes in Patients with Breast Carcinoma / M.Takeuchi et al. / p236~236
  • Workshop 89.Study of the Immunological Competence of Regional Lymphnodes in Breast Cancer / T.Shimizu et al. / p236~236
  • Workshop 90.Clinical and Fundamental Investigations into Immunological Defence Mechanism against Metastasis to Axillary Lymph Nodes in Breast Cancer Patients / Y.Nakajima et al. / p236~236
  • Workshop 91.Influence of Aging on Immune Activity of Regional Lymph Nodes in Breast Cancer / H.Matsukawa et al. / p237~237
  • Workshop 92.Therapeutic Planning of Stages II and IVS Neuroblastoma According to the Amplifi-cation of N-myc Oncogene / A.Nakagawara et al. / p237~237
  • Workshop 93.Role of Surgery in the Multimodal Therapy of Advanced Neuroblastoma / Y.Hata et al. / p237~237
  • Workshop 94.An Evaluation of the Therapeutic Results of Solid Malignant Tumors in Children / S.Ogita et al. / p238~238
  • Workshop 95.A Group Study for the Establishment of Treatment Protocols for Advanced Neuro-blastoma / S.Sawaguchi et al. / p238~238
  • Workshop 96.Multidisciplinary Treatment Studies on Wilms′Tumor in Kitakanto Region / H.Muchi et al. / p238~238
  • Workshop 97.Effects of High-Dose Methotrexate on Gonadal Functions in Children of Osteosar-coma / A.Yokogawa et al. / p239~239
  • Workshop 98.New Device for Immobilisation of Young Children in the Proton Irradiation Therapy / H.Ohkawa et al. / p239~239
  • Workshop 99.The Role of Radiotherapy in Pediatric Oncology / T.Watari et al. / p239~239
  • Workshop 100.Bone Marrow Transplantation in Pediatric Solid Tumor / S.Yokoyama et al. / p240~240
  • Workshop 101.A Comparative Study of Mitoxantrone(MXT)and Adriamycin(ADM)in Patients with Non-Hodgkin's Lymphoma(NHL): A Cooperative Study / T.Ohnoshi et al. / p240~240
  • Workshop 102.Alternating Combination Chemotherapy with THP-COP and BHAC-VMP in Non-Hodgkin′s Lymphoma(NHL) / K.Ezaki et al. / p240~240
  • Workshop 103.A New Salvage Chemotherapy for Refractory Non-Hodgkin′s Lymphoma (NHL) with 4-drug Combination of Mitoxantrone,Etoposide,Cisplatin and Prednisolone(MEPP) / K.Ueno et al. / p241~241
  • Workshop 104.A System of Medical Examination and Multi-Modal Treatment for Non Hodgkin's Lymphoma / T.Yoshida et al. / p241~241
  • Workshop 105.Results of Radiation Therapy for Extranodal Non-Hodgkin′s Lymphoma in the Head and Neck A Study of Japan Lymphoma Radiation Therapy Study Group / J.Horiuchi et al. / p241~241
  • Workshop 106.Treatment of Primary Extranodal Lymphoma / M.Nishikori et al. / p242~242
  • Workshop 107.Multi-Modal Treatment for Extranodal Malignant Lymphoma / E.Sanuki et al. / p242~242
  • Workshop 108.Treatment for Primary Malignant Lymphoma in the Digestive Tract / N.Sakata et al. / p242~242
  • Workshop 109.Chemotherapy for High Grade and Refractory NHL with M-BACOD and Its Modified Regimen / H.Ogata et al. / p243~243
  • Workshop 110.The Intermediate Dose of Cytosine Arabinoside(IDara-C)in the Treatment of Refractory Acute Leukemia / N.Inagaki et al. / p243~243
  • Workshop 111.Low-Dose 4N-Behenoyl-β-D-Arabinofuranosylcytosine(LD-BHAC)in the Treatment of Atypical Leukemia / H.Nakada et al. / p243~243
  • Workshop 112.Retinoid in the Treatment of Atypical Leukemia / H.Tsutani et al. / p244~244
  • Workshop 113.Effect of the Chemotherapy for ATL with Cyclophosphamide, Vindesine and Pred-nisolone(CV′P) / K.Uozumi et al. / p244~244
  • Workshop 114.The Role of Total Skin Electron Beam Irradiation in the Treatment of Adult T Cell Leukemia(ATL) / M.Nakano et al. / p244~244
  • Workshop 115.Surgical Treatment for Spinal Metastasis / H.Matsuzaki et al. / p245~245
  • Workshop 116.Surgical Treatment of Metastatic Spinal Tumor / S.Uchiyama et al. / p245~245
  • Workshop 117.Treatment of Metastatic Spinal Tumors by Posterior Stabilization with Instrumentation / M.Murase et al. / p245~245
  • Workshop 118.A Guideline of Surgical Treatment for Metastatic Spinal Tumor / K.Yonenobu et al. / p246~246
  • Workshop 119.Prosthetic Replacement Surgery for Metastatic Spinal Tumor / K.Ono et al. / p246~246
  • Workshop 120.Management for Metastatic Spinal Tumors / S.Tatezaki et al. / p246~246
  • Workshop 121.Posterior Decompression and Stabilization for Malignant Spinal Tumor / Y.Miyaji et al. / p247~247
  • Workshop 122.Surgical Treatment for Primary Spine Tumor / H.Kitahara et al. / p247~247
  • Workshop 123.Reconstructive Surgery with Spinal Instrumentation for Spinal Tumor / K.Abumi et al. / p247~247
  • Workshop 124.Surgery of Huge Tumors of the Sacrum:From Approach to Reconstruction / K.Tomita et al. / p248~248
  • Workshop 125.Surgical Treatment of Bone and Soft Tissue Tumors in Pelvic Region / H.Takahashi et al. / p248~248
  • Workshop 126.Usefulness of High Resolution MRI in the Diagnosis of Spinal Dissemination of Intracranial Gliomas / J.Yamashita et al. / p248~248
  • Workshop 127.Treatment of Cervical Spinal Cord Tumors by En-Bloc Laminoplasty / Y.Katoh et al. / p249~249
  • Workshop 128.Malignant Tumors in the Spinal Epidural Space--Methods and Results of Treatment of 11 Cases / A.Imakiire et al. / p249~249
  • Workshop 129.Surgical Treatment for Spinal Cord Tumor / K.Masaki et al. / p249~249
  • Workshop 130.The Results of Surgical Treatment of Spinal Cord Tumor / Y.Tokuhashi et al. / p250~250
  • Workshop 131.Effect of New Technic for Primary Spinal Cord Tumor / T.Homma et al. / p250~250
  • Workshop 132.Image Diagnosis of Malignant Melanoma with In-111-Monoclonal Antibody 96.5 / H.Oyamada et al. / p250~250
  • Workshop 133.Experience of Combination Chemotherapy with DTIC,ACNU and VCR in Malignant Melanoma of Oral and Maxillofacial Region / Y.Mizutani et al. / p251~251
  • Workshop 134.Multidisciplinary Treatment for Malignant Melanoma of the Head and Neck / H.Saito et al. / p251~251
  • Workshop 135.Combination Chemotherapy(DTIC,ACNU and VCR)and Cryosurgery for Cases of Primary Malignant Melanoma of the Female Genital Tract / A.Takahashi et al. / p251~251
  • Workshop 136.Results of Cumulative Therapy for Cutaneous Malignant Melanoma in Our Clinic / T.Arao et al. / p252~252
  • Workshop 137.Recent Advances for Radiation Therapy in the Treatment of Malignant Melanoma--Fast Neutron Radiation and Hyperthermia in Combination with Radiation / S.Mori et al. / p252~252
  • Workshop 138.The Status of Combined Chemotherapy for Malignant Melanoma / K.Ishihara et al. / p252~252
  • Workshop 139.5 Year Survival Rate of Cervical Esophageal Cancer / M.Uchida et al. / p253~253
  • Workshop 140.The Survival Rates for Gastric Cancer Patients Who Underwent Surgical Operations / J.Fujimoto et al. / p253~253
  • Workshop 141.Post-operative Cumulative Survival Rate in Patients with Gastric Cancer / K.Inoue et al. / p253~253
  • Workshop 142.Factors Affecting Therapeutic Efficacy and Survival of Advanced Gastric Cancer Patients on Cancer Chemotherapy / H.Takahashi et al. / p254~254
  • Workshop 143.The Problems of Postoperative Adjuvant Chemotherapy for Gastric Cancer / Y.Kunii et al. / p254~254
  • Workshop 144.Clinical Evaluation of Postoperative Adjuvant Chemotherapy for the Gastric Cancer / K.Takesita et al. / p254~254
  • Workshop 145.Results of Surgical Treatment and Effects of Chemo-Endocrine Therapy with Tamox-ifen(TAM)for Gastric Scirrhus(Diffuse Carcinoma of the Stomach) / S.Nakamura et al. / p255~255
  • Workshop 146.Effect of Hyperthermo-chemotherapy with Continuous Hyperthermic Peritoneal Perfusion(CHPP)with General Hypothermia on the Survival Rate of Gastric Cancer / Y.Masuda et al. / p255~255
  • Workshop 147.Significance of Reduction Surgery on Colo-rectal Cancer / M.Ikeguchi et al. / p255~255
  • Workshop 148.Clinical Effect of PSK as an Adjuvant Immunochemotherapy after Radical Operations of Colorectal Cancer--Colon Cancer Chemotherapy Study Meeting in Hokuriku / S.Takashima et al. / p256~256
  • Workshop 149.Surgical Results in Patients with Rectal Cancer / T.Kato et al. / p256~256
  • Workshop 150.Cumulative Survival Rates of Hepatectomies for Hepatocellular Carcinoma / M.Suenaga et al. / p256~256
  • Workshop 151.An Assessment of the Therapeutic Effects of One Shot Therapy and Transcatheter Arterial Embolization in Unresectable Hepatocellular Carcinoma / K.Hirai et al. / p257~257
  • Workshop 152.Transcatheter Therapy for Unresectable Hepatocellular Carcinoma / K.Yasumori et al. / p257~257
  • Workshop 153.Combined Modality Treatment for Lung Cancer and Its Survival / M.Ohta et al. / p257~257
  • Workshop 154.Immediate Simultaneous Reconstruction in the Treatment of Primary Carcinoma of the Breast / H.Yamamoto et al. / p258~258
  • Workshop 155.Adjuvant Chemotherapy and Radiotherapy for Operable Breast Cancer / T.Kobayashi et al. / p258~258
  • Workshop 156.Clinicopathologic Study of Cervical Adenocarcinoma / I.Konishi et al. / p258~258
  • Workshop 157.Analysis of Prognostic and Loco-Control Factor in Uterine Cervix Cancer with Radiation Therapy / Y.Kikuchi et al. / p259~259
  • Workshop 158.Radiotherapy System and Survival Calculation of a Treated Patients in the National Cancer Center Hospital / S.Egawa et al. / p259~259
  • Workshop 159.Changes of Treatment and Improvement of 5-year Survival Rate in Adenocarcinoma of the Ovary / Y.Tomoo et al. / p259~259
  • Workshop 160.Analysis of 117 Dead Cases of Ovarian Malignancies / T.Kano et al. / p260~260
  • Workshop 161.Controlled Clinical Trials of Chemotherapy in Ovarian Cancer / H.Tamura et al. / p260~260
  • Workshop 162.Radiation Therapy versus Endocrine Therapy for Stage C Carcinoma of the Prostate / H.Moriyama et al. / p260~260
  • Workshop 163.Evaluation of Adjuvant Chemotherapy(AC)for Osteosarcoma(os)Mainly with Adriamycin(ADR) (Final Report)Japanease Orthopaedic Oncology Group / K.Furuse et al. / p261~261
  • Workshop 164.Prognostic Study on Patients with Osteosarcoma for Past 30 Years of Experience / H.Tsuchiya et al. / p261~261
  • Workshop 165.Treatment and Prognosis of Malignant Fibrous Histiocytoma of Bone / M.Itagaki et al. / p261~261
  • Workshop 166.Evaluation of Prognostic Factors Related to Results of Treatment for Malignant Soft Tissue Tumors / T.Ishida et al. / p262~262
  • Workshop 167.Effect of Circumstances of Organs on the Grade of Cancer Malignancy / T.Nakamura et al. / p262~262
  • Workshop 168.Invasive Property of Brain Tumor Cells in vitro--Correlation between Malignancy and Invasiveness Using Invasion Test / T.Okumura et al. / p262~262
  • Workshop 169.Grading of Malignancy in Patients with Squamous Cell Carcinoma of the Tongue / H.Hiratsuka et al. / p263~263
  • Workshop 170.Correlation between Histological Type and Epidermal Growth Factor Receptor of the Thyroid Tumor / H.Masuda et al. / p263~263
  • Workshop 171.The Prognostic Value of Flow Cytometric DNA Analysis in Human Esophageal Carcinomas / K.Sanekata et al. / p263~263
  • Workshop 172.Expression of EGF Receptors on Esophageal Carcinomas, Compared with Other Tumor Markers / S.Ikeuchi et al. / p264~264
  • Workshop 173.Malignancy of Gastric Cancer According to DNA Ploidy Pattern and Tumor Markers / K.Sugiyama et al. / p264~264
  • Workshop 174.A Study of Nuclear DNA Ploidy Patterns of Gastric Carcinoma / H.Yosino et al. / p264~264
  • Workshop 175.Mitotic Activity of Cancer Cells and Survival of Gastric Cancer Patients / Y.Tabuchi et al. / p265~265
  • Workshop 176.Malignancy of the Stomach Cancer Decided by the Tumor Volume Doubling Time,the Transplantability into Nude Mice and the Capacity of Protein Synthesis in vitro / K.Bando et al. / p265~265
  • Workshop 177.Correlation of CEA Tissue and Serum Positivity in Gastric Cancer Patients / R.Kirchner et al. / p265~265
  • Workshop 178.Malignant Characteristic and Prognosis of Gastric Cancer Evaluated from Serum Glycoproteins / K.Ogoshi et al. / p266~266
  • Workshop 179.A Study on Mitotic Activity of Human Gastric and Colorectal Cancers / K.Imanishi et al. / p266~266
  • Workshop 180.Clinicopathological Significance of Tissue Human Chorionic Gonadotropin(hCG)in Colorectal Carcinoma / T.Kosaka et al. / p266~266
  • Workshop 181.Microangiographic Study on the Evolution of Colorectal Cancer / T.Shimoyama et al. / p267~267
  • Workshop 182.Comparative Study of Doubling Time between Gastroenterological Cancer / Y.Takahashi et al. / p267~267
  • Workshop 183.Not Received / /
  • Workshop 184.Flow Cytometric Cellular DNA-RNA Analysis in Primary Lung Cancer and Its Relationship to Early Relapse and Malignant Intensity / N.Yamaoka et al. / p267~267
  • Workshop 185.Estrogen Receptor and Progesterone Receptor as a Biological Marker of Breast Cancer / T.Ikeda et al. / p268~268
  • Workshop 186.Prognostic Value of Histochemical Analysis of Endogenous Estrogen(E2),Car-cinoembryonic Antigen(CEA)and Tissue Polypeptide Antigen(TPA)in Primary Breast Cancer / T.Yoshida et al. / p268~268
  • Workshop 187.Flow Cytometric Cellular DNA-RNA Analysis in Human Breast Carcinomas / S.Hara et al. / p268~268
  • Workshop 188.Relationship between Nuclear DNA Content,Lymph Node Metastasis and Prognosis in Breast Cancer / T.Nishi et al. / p269~269
  • Workshop 189.Differences of Prognosis and Invasive Patterns in Accordance with Histological Types / K.Mizuno et al. / p269~269
  • Workshop 190.A Correlation between Miscellenous Histopathological Factors and Prognosis in Cases of Ovarian Serous Cystadenocarcinoma / M.Tashiro et al. / p269~269
  • Workshop 191.Ploidy and Proliferation in Human Bladder Carcinomas as Measured by Two-parame-ter DNA-RNA Microspectrophotometric Analysis and Its Relations to Histopathology and Clinical Course / K.Naito et al. / p270~270
  • Workshop 192.Factors Relating to Malignant Potential of Grade 2 TCC of the Urinary Bladder / M.Moriyama et al. / p270~270
  • Workshop 193.Relationship between Cell Nuclear DNA in Tissues from Patients with Osteosarcoma and the Prognosis / S.Masuda et al. / p270~270
  • Workshop 194.Microphotometric Analysis of Two Leiomyosarcomas of Bone and Soft Tissue with Progressive Histological Change in Clinical Course / H.Itoh et al. / p271~271
  • Workshop 195.Radiofrequency Capacitive Hyperthermia Combined with Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer / Y.Nishimura et al. / p271~271
  • Workshop 196.Preoperative Treatment with Pelvic Radiation plus 5-Fluorouracil Suppository for Rectal Cancer / M.Niwa et al. / p271~271
  • Workshop 197.Application of Laser for the Rectal Cancer / O.Nishida et al. / p272~272
  • Workshop 198.Sphincter Preserving Operation for Cancer of the Lower Rectum / S.Kodaira et al. / p272~272
  • Workshop 199.Multimodal Treatment of Colorectal Cancer--Experience of Intraoperative Radiation Therapy with or without Preoperative Irradiation / T.Okawa et al. / p272~272
  • Workshop 200.Extended and Limited Procedures in Surgery of Lower Rectal Cancer / K.Hojo et al. / p273~273
  • Workshop 201.Indication and Evaluation of Endoscopic Laser Therapy in Lung Cancer / R.Ono et al. / p273~273
  • Workshop 202.Evaluation of Preoperative Photodynamic Therapy for the Lung Cancer / N.Kawate et al. / p273~273
  • Workshop 203.Co 60 Remote Afterloading Intracavitary Irradiation to the Tracheo-bronchial Cancer Infiltration / T.Kawaguchi et al. / p274~274
  • Workshop 204.The Evaluation of Photodynamic Therapy(PDT)with Hematoporphyrin Derivatives(HpD)in Inoperable Patients with Stage Ia Hilar Type Lung Cancer--Comparison of PDT with Radiation Therapy(RT) / K.Furuse et al. / p274~274
  • Workshop 205.Uneven Fractionation in the Radiation Therapy Combined with Cisplatin for Lung Cancer / Y.Takai et al. / p274~274
  • Workshop 206.A Phase II Study of Epirubicin in Lung Cancer / M.Kawahara et al. / p275~275
  • Workshop 207.Study on a Long-term Adjuvant Chemotherapy for Lung Cancer / M.Imaizumi et al. / p275~275
  • Workshop 208.A Randomized Trial of Chemotherapy Alone or with Chest Irradiation in Limited Stage Small Cell Lung Cancer(SCLC) / S.Kawahara et al. / p275~275
  • Workshop 209.A Randomized Study of the Alternating Noncross Resistant Chemotherapy for the Patients with SCLC / M.Takada et al. / p276~276
  • Workshop 210.Not Received / /
  • Workshop 211.Not Received / /
  • Workshop 212.A Randomized Trial Comparing Cisplatinum,Vindesine and Bleomycin vs Mitomycin C,Vindesine and Bleomycin in Patients with Advanced Non-Small Cell Lung Cancer / K.Nishii et al. / p276~276
  • Workshop 213.Combination Chemotherapy of Cisplatin, Vindesine and Mitomycin C(CVM)for Non-Small Cell Lung Cancer / M.Fukuoka et al. / p276~276
  • Workshop 214.Combination Chemotherapy for Non-Small Cell Lung Cancer with Cisplatin,Vinblas-tine and 5-fluorouracil / K.Aiba et al. / p277~277
  • Workshop 215.Cisplatin and Vindesine Chemotherapy for Advanced Non-Small Cell Lung Cancer / T.Shinkai et al. / p277~277
  • Workshop 216.Evaluation of Postoperative Immunochemotherapy for Non-Small Cell Lung Cancer Patients by T,N Factors / T.Ikeda et al. / p277~277
  • Workshop 217.Clinical Trials of Local Hyperthermia in the Treatment of Peripheral Type Lung Cancers and Lung Cancer with Malignant Effusion / R.Amemiya et al. / p278~278
  • Workshop 218.Percutaneous CT Guided Intratumor Injection(CT-ITI)of Absolute Ethanol for Peripheral Lung Cancer / Y.Shinohara et al. / p278~278
  • Workshop 219.Lymphocyte Subsets of Senile Patients with Cancer / H.Mugitani et al. / p278~278
  • Workshop 220.Risk Factor of Operation in Aged Patients with Cancer / K.Manabe et al. / p279~279
  • Workshop 221.Clinical Study on Brain Tumors in the Aged / T.Kodama et al. / p279~279
  • Workshop 222.Therapeutic Results of High Aged Head and Neck Tumor Patients / G.Mizojiri et al. / p279~279
  • Workshop 223.Treatment Results of Radiation Therapy for Head and Neck Cancer in the Patients with Advanced Age / N.Masaki et al. / p280~280
  • Workshop 224.Surgical Treatment for Eldery Patients with Carcinoma of the Esophagus / M.Kitamura et al. / p280~280
  • Workshop 225.Treatment of Cancer of Cardiac Area in the Aged Patients / Y.Kawaura et al. / p280~280
  • Workshop 226.Surgical Treatment of Gastric Cancer on Patients over 80 Years / S.Waki et al. / p281~281
  • Workshop 227.Evaluation of Surgical Treatment and Prognosis for Gastric Cancer in the Aged / H.Ueda et al. / p281~281
  • Workshop 228.Colorectal Carcinoma in Aged Patients / T.Ikehara et al. / p281~281
  • Workshop 229.Surgical Treatment of Colorectal Cancer in Patients over the Age of 80 Years / I.Fukuda et al. / p282~282
  • Workshop 230.Experiences in the Surgical Treatment of Colorectal Cancer in the Elderly over Seventies / Y.Yamamoto et al. / p282~282
  • Workshop 231.Surgical Results in Elderly Cases with Rectal Cancer / T.Sekine et al. / p282~282
  • Workshop 232.Actualities and Problems of Hepatic Resection of Hepatocellular Carcinoma in the Aged Patients / M.Nonaka et al. / p283~283
  • Workshop 233.Clinicopathological Study of High Aged Patients(over 70 Yrs Old)with Gallbladder Carcinoma / A.Kawaguchi et al. / p283~283
  • Workshop 234.Indication and Significance of Pancreatoduodenectomy for Advanced-aged Patients / K.Yamamoto et al. / p283~283
  • Workshop 235.A Clinical Study of Surgery for Bronchogenic Carcinoma in the Elderly / K.Kawahara et al. / p284~284
  • Workshop 236.Surgical Treatment of Lung Cancer in the Elderly / S.Kosaba et al. / p284~284
  • Workshop 237.The Efficiency of Intensive Combination Chemotherapy for Lung Cancer in the Elderly / N.Hara et al. / p284~284
  • Workshop 238.Treatment of Extensive-Stage Small Cell Carcinoma of the Lung in the Aged Patients / S.Hiraki et al. / p285~285
  • Workshop 239.Characteristics and Prognosis of the Breast Cancer on Older than 70 Years Women / K.Kanda et al. / p285~285
  • Workshop 240.Studies on Uterine Cervical Cancer Patients over 70-Years Old / H.Noguchi et al. / p285~285
  • Workshop 241.Treatment of Ovarian Malignancies / H.Nishimura et al. / p286~286
  • Workshop 242.Treatment of Bladder Cancer in Elderly Patients / T.Okano et al. / p286~286
  • Workshop 243.Treatment for the Elderly Patients with Bladder Cancer / H.Kivohara et al. / p286~286
  • Workshop 244.Treatment for Bladder Cancer in Elderly Patients / K.Ohmura et al. / p287~287
  • Workshop 245.Measures for Cancer Pain in Patients with Terminal Stage Lung Cancer--Effect of "Brompton Mixture" / K.Ninomiya et al. / p287~287
  • Workshop 246.Relief of the Pain of Unresectable Pancreatic Carcinoma by Intraoperative Irradiation and Intraoperative Chemical Splanchniectomy / Y.Suzuki et al. / p287~287
  • Workshop 247.The Treatments of Advanced Pancreatic Cancer / Y.Yokoyama et al. / p288~288
  • Workshop 248.Radiotherapy for Metastatic Bone Tumor / T.Yokote et al. / p288~288
  • Workshop 249.Vertebral Body Replacement for Metastatic Tumor of the Spine / E.Shimozaki et al. / p288~288
  • Workshop 250.Laser Stimulation Therapy Using a Diode Laser to Relieve Cancer-associated Pains / H.Shinohara et al. / p289~289
  • Workshop 251.Case Reports of CT Guided Celiac Nerve Plexus Block for Cancer Pain / T.Sanda et al. / p289~289
  • Workshop 252.Not Received / /
  • Workshop 253.WHO Method for Relief of Cancer Pain and the Result of the Field-testing in Japanese Cancer Patients / F.Takeda et al. / p289~289
  • Workshop 254.Factors of Rejection to the Treatment of Retinoblastoma / T.Mizuguchi et al. / p290~290
  • Workshop 255.Surface-cooling Hypothermic Anesthesia for CHPP (Continuous Hyperthermic Peri-toneal Perfusion) / M.Utsugi et al. / p290~290
  • Workshop 256.The Retrospective Studies on the Prognosis of Oncologic Emergency Operation / K.Hiraga / p290~290
  • Workshop 257.Familial Clustering of Head and Neck Tumor / M.Fujii et al. / p291~291
  • Workshop 258.Family Carcinogenesis in the Head and Neck Region / Y.Matsumura et al. / p291~291
  • Workshop 259.Familial Occurrence of Differentiated(Non-medullary)Thyroid Carcinoma / O.Ozaki et al. / p291~291
  • Workshop 260.Development of Cancers of the Large Intestine in One Family Line of Familial Polyposis / H.Isai et al. / p292~291
  • Workshop 261.Familial Non-polypotic Colorectal Cancer / H.Tomoda et al. / p292~292
  • Workshop 262.Study of the Influence of Family History on the Incidence of Breast Cancer / T.Koida et al. / p292~292
  • Workshop 263.The Cases of Renal Cancer Occurred in a Family / A.Matsubara et al. / p293~293
  • Workshop 264.Clinical Investigation of Familial Clustering of Cancer / T.Nomizu et al. / p293~293
  • Workshop 265.A Case of Non-simultaneous Five Primary Cancers in Different Organs and Her Offspring with Colorectal Cancers / A.Tokunaga et al. / p293~293
  • Workshop 266.Spontaneous Regression of Hepatocellular Carcinoma A Case Report / M.Suzuki et al. / p294~294
  • Workshop 267.Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases (XII) -The Analytical Study of the Malignant Brain Tumor Patients- / S.Nakagawa et al. / p294~294
  • Workshop 268.Preoperative Irradiation for the Carcinoma of Periampullary Region / O.Ishikawa et al. / p294~294
  • Workshop 269.Diagnosis of Intrapancreatic Development of Pancreatic Head Cancer and Extended Radical Operation Combined with Operative Irradiation / A.Nakao et al. / p295~295
  • Workshop 270.Clinical Studies on Intraoperative Radiotherapy and Postoperative Conformation Radiotherapy Applied to Pancreatic Carcinoma / Y.Tanaka et al. / p295~295
  • Workshop 271.Hyperthermochemotherapy for Pancreatic Cancer / Y.Yamamoto et al. / p295~295
  • Workshop 272.Adriamycin,5-Fluorouracil,Mitomycin-C(AFM)Combination Regimen with Induced Hypertension Chemotherapy(IHC)in Advanced Pancreatic Carcinoma / M.Hoshi et al. / p296~296
  • Workshop 273.Short Ischemia of Tumor by Noradrenalin Administered into Tumor Feeding Arteries after Chemotherapy Improved Antitumor Effect on Pancreas Cancer / T.Sato et al. / p296~296
  • Workshop 274.Extended Operation for Cancer of the Pancreas with Reference to Factors Influencing Spread and Recurrence / T.Manabe et al. / p296~296
  • Workshop 275.Combined Modality Therapy for Advanced Pancreatic Cancer / N.Kuno et al. / p297~297
  • Workshop 276.A Combined Therapy with Hyperthermia and Radiation for Bone Metastasis from Renal Cell Carcinoma / S.Kanoh et al. / p297~297
  • Workshop 277.A Combined Treatment of 8 MHz RF-hyperthermia with/without Chemoembolization or Irradiation for advanced Renal Cancer / K.Nakaiima et al. / p297~297
  • Workshop 278.Minimal Surgical Intervention for Renal Cell Carcinoma(RCC)Invading into Inferior Vena Cava(IVC)--Use of Preoperative Chemoembolization and Artificial Vascular Patch / T.Kato et al. / p298~298
  • Workshop 279.A Comparison of Preoperative Embolization and Arterial Injection in Renal Cancer / T.Asahi et al. / p298~298
  • Workshop 280.Combination Therapy of Vinblastine and Nicardipine in Human Renal Cell Carcinoma / M.Masuda et al. / p298~298
  • Workshop 281.Adjuvant Therapy for Renal Cell Carcinoma before and after Nephrectomy / H.Nakazawa et al. / p299~299
  • Workshop 282.Immunotherapy for Renal Cell Carcinoma / T.Tsukarnoto et al. / p299~299
  • Workshop 283.Clinical Results of Human Interferon Gamma(S-6810)for Renal Cell Carcinoma / T.Machida et al. / p299~299
  • Workshop 284.Combination Chemotherapy for Advanced Renal Cell Carcinoma with Interferon and MVP Therapy (MTX,VBL and PEP) / Y.Satomi et al. / p300~300
  • Workshop 285.Immunotherapy by Administration of Autologous Lymphokine-Activated Killer Cells and Interleukin 2 for Renal Cancer / E.Nakano et al. / p300~300
  • Workshop 286.Extended Radical Nephrectomy for Renal Cell Carcinoma Extending into the Inferior Vena Cava / K.Okada et al. / p300~300
  • Workshop 287.Surgical Management of Renal Cancer with Vena Caval Involvement / S.Isaka et al. / p301~301
  • Workshop 288.The Removal of Renal Carcinoma Thrombus Extending into the Inferior Vena Cava / F.Kondo et al. / p301~301
  • Workshop 289.The Effect of Bismuth Subnitrate on Cisplatin Nephrotoxicity / J.Chen et al. / p301~301
  • Workshop 290.Significance of FOM and Evaluation of Renal Function on CDDP Therapy for Urothelial Cancer / S.Yogi et al. / p302~302
  • Workshop 291.The Modification of the Kinetics of Cisplatin with Hypertonic Saline and/or Fos-fomycin / M.Horiuchi et al. / p302~302
  • Workshop 292.Two Way Continuous Hyperthermic Peritoneal Perfusion Therapy Using High-dose CDDP and STS for Patients of Peritoneal Metastasis from Gastric Cancers / R.Miyata et al. / p302~302
  • Workshop 293.Combined Effect of Cis-diamminedichloroplatinum(CDDP) and Sodium Thiosulfate(STS)for Lung Cancer / A.Hirosawa et al. / p303~303
  • Workshop 294.Antiemetic Effect of High-Dose Metoclopramide(MCP)in Cisplatin Therapy / T.Yamada et al. / p303~303
  • Workshop 295.Anti-emetic Treatment with Metoclopramide and Other Drugs during CDDP Therapy / N.Kodama et al. / p303~303
  • Workshop 296.Antiemetic Efficacy of High-Dose Metoclopramide and Dexamethasone in Patients Receiving Cisplatin-Based Chemotherapy / T.Tamura et al. / p304~304
  • Workshop 297.A Randomized Crossover Comparison of the Antiemetic Activity of High-Dose Metoclopramide(MCP)and High-Dose MCP+Methylprednisolone(MP) against CDDP-Induced Emesis / K.Matsui et al. / p304~304
  • Workshop 298.A Pilot Study of Methylprednisolone for the Prevention of Cis-Diamminedichloro-platinum(II)-Induced Nausea and Vomiting / S.Ozono et al. / p304~304
  • Workshop 299.Scalp Hypothermia Combined with Tocopherol to Prevent Adriamycin-Induced Hairloss / Y.Mizoi et al. / p305~305
  • Workshop 300.Neo-Adjuvant Chemotherapy with UFT,Adriamycin and CoenzyrmeQ₁₀ / N.Hyo et al. / p305~305
  • Workshop 301.Not Received / /
  • Workshop 302.Recombinant Human Granulocyte Colony Stimulating Factor(Hu Re G-CSF) Induces Granulocytopoiesis in vivo / T.Okabe et al. / p305~305
  • Workshop 303.Clinical Study of Colony-Stimulating Factor from Human Urine (P-100) on the Granulocytopenia Induced by Chemotherapy for Malignant Tumors in Gynecology / K.Ueda et al. / p306~306
  • Workshop 304.Antibiotic Therapy in Cancer Patients with Granurocytopenia / M.Sano et al. / p306~306
  • Workshop 305.Simplified Sterile Isolator is Effective Prevention against Infection of Patients with Granulocytopenia / I.Adachi et al. / p306~306
  • Workshop 306. The Effect of Lithium Carbonate on Chemotherapy-Induced Myelosuppression / S.Kodama et al. / p307~307
  • Workshop 307.Primary Effect of PP Therapy(Including Intravenous and Arterial Injection) on Carcinoma of the Oral Cavity / I.Tohnai et al. / p307~307
  • Workshop 308.Prevention of Side Effect of Intra-arterial Infusion Therapy for Liver Cancer
  • By Monitering the Concentration of Anticancer Drugs / Y.Une et al. / p307~307
  • Workshop 309.Transcatheter Arterial Chemo-Embolization Therapy for Patients with Infantile Hepatoblastoma / T.Ichihara et al. / p308~308
  • Workshop 310.Supporting Therapy of Intra-arterial Chemotherapy in Advanced Breast Cancer / K.Asaishi et al. / p308~308
  • Workshop 311.Toxicity of Cisplatin,Adriamycin and Cyclophosphamide(CAP)Therapy / Y.Osuga et al. / p308~308
  • Workshop 312.Distant Metastases of Differentiated Thyroid Cancer / N.Kasai et al. / p309~309
  • Workshop 313.Study on Recurrent Cases of Five-year Survivors after Curative Resection of the Thoracic Esophagus / Y.Sekine et al. / p309~309
  • Workshop 314.Pathological Evaluation of the Patients with Poorly Differentiated Adenocarcinoma of the Stomach Who Died More Than 5 Years after Operation / H.Usuki et al. / p309~309
  • Workshop 315.The Study of the Cases That Died of the Late Recurrence of Gastric Carcinoma after Curative Resection / T.Tani et al. / p310~310
  • Workshop 316.Evaluation of Late Recurrent Cases of Gastric Cancer / T.Fukuda et al. / p310~310
  • Workshop 317.Study on the Cases with Late Onset of Recurrent Gastric Cancer / Y.Yamamura et al. / p310~310
  • Workshop 318.Studies on Gastric Cancer Patients Who Died of Recurrence More Than Five Years after Curative Resection / N.Saito et al. / p311~311
  • Workshop 319.Mode of Recurrence in Gastric Cancer Patients with More Than 5-year Disease-free Period
  • Change with Adjuvant Chemotherapy / M.Hiratsuka et al. / p311~311
  • Workshop 320.Survey on Recurrent Cancers of the Large Intestine--Focusing on Recurrence Cases after 5 Postoperative Years or More / M.Kiriyama et al. / p311~311
  • Workshop 321.Liver Metastases Occured More Than 5 Years after Radical Operation Report of 4 Patients / I.Ozawa et al. / p312~312
  • Workshop 322.Recurrence of Lung Cancer Five or More Years after Complete Pulmonary Resection / K.Kunishima et al. / p312~312
  • Workshop 323.Late Recurrences of Breast Cancer at Intervals of over Five Years after Mastectomy / S.Miura et al. / p312~312
  • Workshop 324.A Study on Cases of Breast Cancer Relapsing over 5 Years after Operation / S.Takashima et al. / p313~313
  • Workshop 325.Cases with Recurrence of Breast Cancer More Than Five Years after Surgery / H.Sasaki et al. / p313~313
  • Workshop 326.Late Recurrence of Uterine Cervical Carcinoma after Radical Hysterectomy / I.Shiozawa et al. / p313~313
  • Workshop 327.The Pathological Consideration about the Two Cases of Recurrent Uterine Cervical Carcinoma(CC)More Than 10 Years after Operation / A.Yamaga et al. / p314~314
  • Workshop 328.Clinical Evaluation of Cases of Metastatic Renal Cell Carcinoma Presenting after a Tumor-Free Interval of Greater Than Five Years Post Radical Nephrectomy / M.Fukuda et al. / p314~314
  • Workshop 329.Clinical Studies on Renal Cell Carcinoma Metastasized over Five Years after Ne-phrectomy / T.Onishi et al. / p314~314
  • Workshop 330.A Case of Renal Cell Carcinoma which Recurred in the Rest Kidney and Died of Cerebellar Hemangioblastoma
  • Hipple-Lindau Disease / S.Ichijo et al. / p315~315
  • Workshop 331.Long Term Prognosis after Total Cystectomy in Patients with Invasive Bladder Cancer / A Yamasaki et al. / p315~315
  • Workshop 332.A Case Report of Late Pulmonary Metastasis from Osteosarcoma / T.Yagi et al. / p315~315
  • Workshop 333.Late Recurrence of 3 Children with Cancer:The Problems of Postoperative Chemotherapy / K.Nagashima et al. / p316~316
  • Workshop 334.Pulmonary Metastasis Resected after Long Disease Free Intervals (More Than 5 Years) / N.Miyazawa et al. / p316~316
  • Workshop 335.Not Received / /
  • Workshop 336.The Clinical Pharmacokinetics of Etoposide in Patients with Gynecologic Malignancy / T.Kurose et al. / p316~316
  • Workshop 337.Clinical Efficacy of Etoposide(VP16-213)and MECA Therapy in Trophoblastic Disease / M.Maeda et al. / p317~317
  • Workshop 338.Clinical Evaluation of Etoposide and Cisplatin in Gestational Choriocarcinoma / K.Kanazawa et al. / p317~317
  • Workshop 339.Present Problems of Treatment for Choriocarcinoma Patients / T.Ishizuka et al. / p317~317
  • Workshop 340.Treatment for Choriocarcinoma Having a Long Latent Period / M.Takayama et al. / p318~318
  • Workshop 341.Treatment of Brain Tumor by Magnetic Induction Hyperthermia Using Ferromagnetic Implant with Low Curie Point--Experimental Study on Rat Brain Tumor Model / T.Tanaka et al. / p318~318
  • Workshop 342.Increasing Anticancer Effects of Charge-Changed Liposomes Including Various Drugs in vitro / K.Nishihara et al. / p318~318
  • Workshop 343.Pharmacokinetics and Toxicity of Intrathecal Administration of Recombinant Interleukin-2 / S.Miyatake et al. / p319~319
  • Workshop 344.Studies on Immunological Parameters during Interferon Therapy for Malignant Brain Tumors--Changes of T-cell Subsets by Method of Two-Color Analysis / M.Nagai et al. / p319~319
  • Workshop 345.The Interstitial Irradiation of Malignant Gliomas--After-loading Technique / S.Shibui et al. / p319~319
  • Workshop 346.Experience of 80 Cases of Brain Tumors Treated by Boron-neutron Capture Therapy / H.Hatanaka et al. / p320~320
  • Workshop 347.Not Received / /
  • Workshop 348.Surgical Guiding with Flow Cytometry(FCM)for Malignant Gliomas--Rapid Cell Cycle Analyses and General Application of FCM for Maignant Neo-plasms / H.Yamamoto et al. / p320~320
  • Workshop 349.Early Phase II Study of the Adoptive Immunotherapy of Patients with Meningeal Gliomatosis by LAK Cells / K.Shimizu et al. / p320~320
  • Workshop 350.Antitumor Efficacy of Recombinant Interferon-β Human Glioma / Y.Miyao et al. / p321~321
  • Workshop 351.Intentional Radiochemotherapy for Malignant Glioma Based on Experimental Analy-sis / M.Kitahara et al. / p321~321
  • Workshop 352.Effects of Intraarterial ACNU against Recurrent Malignant Gliomas Following Chemotherapy with Systemic Nitrosoureas / Y.Ushio et al. / p321~321
  • Workshop 353.Hypofractionation(5Gy Twice a Week)and/or Misonidazole in the Radiation Therapy of Glioblastoma / K.Hayakawa et al. / p322~322
  • Workshop 354.Intraoperative Radiotherapy and Brachytherapy for Glioblastoma / H.Tanaka et al. / p322~322
  • Workshop 355.Radiation Therapy for Retinoblastoma / I.Tsukiyama et al. / p322~322
  • Workshop 356.Proton Radiotherapy for Ocular Melanoma / S.Morita et al. / p323~323
  • Workshop 357.Animal Experiments of Lagendijk′s Microwave Applicator for Hyperthermic Treatment of the Eyeball / A.Kaneko et al. / p323~323
  • Postersession 1.Subpopulation of Lymphocytes Infiltrated in Cancer Tissues of Head and Neck Regions:Correlation of Subpopulation and Clinico-pathologic Findings / J.Hirota et al. / p324~324
  • Postersession 2.A Diagnostic Evaluation of Excisional Biopsy with Patients with T1N0 Carcinoma of the Tongue / H.Kasai et al. / p324~324
  • Postersession 3.Studies on Clinico-Pathological Malignancy of Tongue Cancer / H.Sunakawa et al. / p324~324
  • Postersession 4.Depth of Invasion of Carcinoma of the Tongue and Its Recurrence Factor / T.Kawaguchi et al. / p325~325
  • Postersession 5.Long Survivor after Radiotherapy of Tongue Carcinoma / T.Inoue et al. / p325~325
  • Postersession 6.Clinicopathological Study of 38 Autopsy Cases with Oral Malignant Tumor -1st Report Metastases- / K.Obata et al. / p325~325
  • Postersession 7.Study on Cellular Immunity in DMBA Induced Hamsters′Tongues Neo-plasia Forma-tion:Peritoneal Macrophage Funciton (Superoxide Production Ability) / Y.Shigeta et al. / p326~326
  • Postersession 8.A Study on Subsets of Peripheral Blood Lymphocytes and Various Skin Testes in Course of Treatment of Oral Cancer Patients / K.Ryoke et al. / p326~326
  • Postersession 9.Effect of Combination Immunotherapy of OK-432 and SPG on Peripheral Blood Monouclear Leucocytes of Cancer Patients / Y.Umezu et al. / p326~326
  • Postersession 10.Application of Flow Cytometry for Oral Solid Tumors / R.B.Chen et al. / p327~327
  • Postersession 11.Analysis of Lymphocytes Infiltrated in Cancer Tissues of Patients during Radiation Therapy by the Method of Monoclonal Antibodies of Lyrnpho Cyte Subsets / F.Hamada et al. / p327~327
  • Postersession 12.Radiation-induced Cancer of the Head and Neck / K.Umatani et al. / p327~327
  • Postersession 13.Clinical Survey of Radiation Induced Cancer / K.Ichikawa et al. / p328~328
  • Postersession 14.Radiotherapy of Head and Neck Tumors with Combined Use of Misonidazole and Polychemotherapy / H.Asakura et al. / p328~328
  • Postersession 15.An Evaluation of Multidisciplinary Treatment of Carcinoma of the Maxillary Antrum in Head and Neck Surgery / S.Matsuura et al. / p328~328
  • Postersession 16.Application of the Prosthetic Splint for Reduction of Side Effects during Radiotherapy to an Advanced Aged Patient with Oral Cancers / T.Kawamura et al. / p329~329
  • Postersession 17.Radiotherapy in Aged Laryngeal Cancer Patients / K.Sakaino et al. / p329~329
  • Postersession 18.Treatment Results of Radiation-Chemotherapy for Patients of Carcinoma of the Lower Gum with Bone Invasion / Y.Matayoshi et al. / p329~329
  • Postersession 19.Primary Clearance for Head and Neck Cancer by Combined Radiation with or without Chemotherapy Comparison with Predicting Probability from Multivariate Model by RTOG / Y.Ohizumi et al. / p330~330
  • Postersession 20.Experimental Study on UFT with Concomitant Radiotherapy / J.Tanaka et al. / p330~330
  • Postersession 21.UFT for Head and Neck Cancers:Its Tissue Concentrations and Effect of Lymphocyte Subpopulations / M.Tachibana et al. / p330~330
  • Postersession 22.Administration to Head and Neck Malignant Tumors Concentrations in Serum and Tumor / K.Tsuchikawa et al. / p331~331
  • Postersession 23.In vitro Chemosensitivity of Head and Neck Cancers Evaluated by SDI(Succinate Dehydrogenase Inhibition)Test / K.Tomita et al. / p331~331
  • Postersession 24.Combination Chemotherapy with CDDP in Non-Squamous Cell Carcinoma of the Head and Neck / T.Furusaka et al. / p331~331
  • Postersession 25.Mechanism of Synergism in Combination of 4′-O-Tetrahydropyranyl-Adriamycin,Cisplatin and Peplomycin (Flow Cytometry) / H.Hosoda et al. / p332~332
  • Postersession 26.Combination Chemotherapy with Adriamycins,Cisplatin and Peplomycin for Head and Neck Cancer / Y.Inuyama et al. / p332~332
  • Postersession 27.Alternating Combination Chemotherapy with Cisplatin,Peplomycin,Methotrexate,Mitomycin C and Cisplatin,Peplomycin,Adriamycin,Cyclophosphamide for Advanced Head and Neck Carcinoma / T.Aoyama et al. / p332~332
  • Postersession 28.An Evaluation of Results of Neo-adjuvant Chemotherapy for Maxillary Cancer / M.Igarashi et al. / p333~333
  • Postersession 29.Local Cancer Therapy by Means of Direct Current / M.Yokoyama et al. / p333~333
  • Postersession 30.Interstitial Hyperthermia Using Nd-YAG Laser Irradiation / I.Moriyama et al. / p333~333
  • Postersession 31.Experiences of Primary Reconstruction of Oral Cavity and Mesopharynx by Use of Free Forearm Flap / S.Hanazawa et al. / p334~334
  • Postersession 32.Reconstruction Method of Alveolar Ridge with Porous Hydroxyapatite Blocks and Forearm Free Flap after Mandibulectomy for Commando Operation of Oral Cancer / S.Okabe et al. / p334~334
  • Postersession 33.Relation between Clinico-Pathological Diagnosis and Prognosis in Carcinoma of the Buccal Mucosa and the Lip / A.Miyakawa et al. / p334~334
  • Postersession 34.Treatment Results in Carcinoma of the Mouth Floor at Gunma Cancer Center / B.Satake et al. / p335~335
  • Postersession 35.Treatment Results of Major Salivary Gland Cancer / R.Shimizu et al. / p335~335
  • Postersession 36.Clinical Analysis and Cause of Death of Supraglottic Cancer / H.Miyahara et al. / p335~335
  • Postersession 37.Treatment and Result of Hypopharyngeal Cancer Comparision between before and after Introduction of One Stage Reconstruction / S.Takeoda et al. / p336~336
  • Postersession 38.Surgical and Non-Surgical Treatment Results for Carcinoma with Intracranial Invasion from Extracranial Lesions / T.Murakami et al. / p336~336
  • Postersession 39.Not Received / /
  • Postersession 40.Multidisciplinary Treatment of Malignant Melanoma of the Mouth A Review of Two Cases / H.Tanabe et al. / p336~336
  • Postersession 41.The Clinical Study of Malignant Melanoma during the Last Ten Years in Kagoshima University Hospital Evaluation of Low-Phenylalanine,Low-Tyrosine Diet Therapy / R.Kiyota et al. / p337~337
  • Postersession 43.A Study on 3 Long Term Survival Cases of Head and Neck Cancer with Chemotherapy Alone / T.Takaoka et al. / p337~337
  • Postersession 44.Malignant Fibrous Histiocytoma of the Head and Neck An Analysis of Three Cases / M.Akune et al. / p337~337
  • Postersession 45.Familial Occurrences of Oral Cancer / H.Hara et al. / p338~338
  • Postersession 46.A Clinical Study of the Minor Salivary Gland Carcinoma of the Oropharynx / W.Ohyama et al. / p338~338
  • Postersession 47.Multidisciplinary Treatment of Maxillary Sinus Cancer / T.Kato et al. / p338~338
  • Postersession 48.Urological Significance of PSTI Measurement / Y.Ohishi et al. / p339~339
  • Postersession 49.Clinical Evaluation of Serum Placental Leucine Aminopeptidase Activity in Renal Cell Carcinoma / M.Kuriyama et al. / p339~339
  • Postersession 50.Serum Immunosuppresive Acidic Protein(IAP)in Renal Cell Carcinoma / T.Ueda et al. / p339~339
  • Postersession 51.A Clinical Study of CA 19-9 for Patients with Urological Disease / T.Tanaka et al. / p340~340
  • Postersession 52.Changes in the Level of Polyamines after Operation / T. Koide et al. / p340~340
  • Postersession 53.Clinical Study of Serum Phosphofrucrokinase in Urological Cancers / Y.Takahashi et al. / p340~340
  • Postersession 54.Clinical Study of Serological Parameter in Testicular Tumor / K.Yoshida et al. / p341~341
  • Postersession 55.Clinical Study of Testicular Tumor--Detection of hCG-Concentrated Urine in Patients with Seminoma / T.Suaawara et al. / p341~341
  • Postersession 56.NSE(Neuron Specific Enolase)in Testicular Cancer / A.Itani et al. / p341~341
  • Postersession 57.Seminoma with Slightly Elevated HCG / I.Takahashi et al. / p342~342
  • Postersession 58.Histological Study of Subrenal Capsule Assay(SRCA)in Human Testiculer Tumor / T.Wada et al. / p342~342
  • Postersession 59.Sensitivity Test of Anticancer Agents Using Human Urological Cancer Xenografted in Nude Mice / M.Honda et al. / p342~342
  • Postersession 60.Therapeutic Effects of Anticancer Drugs to Human Wilms′Tumor Transplanted into Nude Mice:Histopathological Studies / S.Yamada et al. / p343~343
  • Postersession 61.Clinical Observation of Testicular Tumors--Clinical Efficacy of Combined Chemotherapy for Disseminated Testicular Tumors / H.Sudoko et al. / p343~343
  • Postersession 62.Paraplegia due to Metastasis of Testicular Tumors / A.Furuhata et al. / p343~343
  • Postersession 63.A Case of Testicular Tumor-Stage IIIc / A.Suzuki et al. / p344~344
  • Postersession 64.Fertility after Treatment for Patients with Testicular Cancer / T.Miyauchi et al. / p344~344
  • Postersession 65.Clinicopathological Evaluation of 103 Cases of Testicular Tumor / K.Nomata et al. / p344~344
  • Postersession 66.Thymidine Kinase and Its Isozyme Activities in Human Thyroid Gland / S.Murakami et al. / p345~345
  • Postersession 67.Clinical Evaluation of Pancreas Cancer-Associated Antigen in Patients with Medullary Thyroid Carcinoma / K.Ueno et al. / p345~345
  • Postersession 68.Effect of Parathyroid Autotransplantation on Plasma PTH Level in Thyroid Carcinoma Surgery / H.Sugiura et al. / p345~345
  • Postersession 69.Treatment of Thyroid Adenocarcinoma with Natural Human Interferon(IFN)-γ / N.Aoki et al. / p346~346
  • Postersession 70.Cisplatin and Adriamycin Therapy for Anaplastic Thyroid Carcinoma / T.Tabei et al. / p346~346
  • Postersession 71.Bone Metastasis of Thyroid Carcinoma / A.Tsuchiya et al. / p346~346
  • Postersession 72.An Evaluation of Recurrent Nerve Palsy due to Radical Surgery for Thyroid Cancer / S.Makino et al. / p347~347
  • Postersession 73.Results of Total Thyroidectomy and Extensive Lymph Node Dissection in Patients with Papillary Thyroid Carcinoma / S.Mizuno et al. / p347~347
  • Postersession 74.Bone Metabolism in Breast Cancer Patients / S.Takeuchi et al. / p347~347
  • Postersession 75.Clinical Features and Treatment of Hypercalcemia Associate with Breast Cancer / H.Tashiro et al. / p348~348
  • Postersession 76.Study of Patients with Bone Recurrent Breast Cancer / M.Kimura et al. / p348~348
  • Postersession 77.Not Received / /
  • Postersession 78.Evaluation of Tumor-Markers(CEA,AFP,Ferritin,TPA and CA15-3) in the Serum of Patients with Recurrent Breast Carcinoma / H.Fukushima et al. / p348~348
  • Postersession 79.Clinical Evaluation of a New Breast Tumor Associated Antigen CA15-3,for Breast Cancer Patients / S.Shimizu et al. / p349~349
  • Postersession 80.Tumor Markers in Breast Cancer--A Comparative Study of CA15-3 and CEA in Clinical Use / H.Sonoo et al. / p349~349
  • Postersession 81.Clinical Study of CA15-3 in Human Breast Cancer / M.Nihei et al. / p349~349
  • Postersession 82.Clinical Evaluation of Cancer Antigen 15-3(CA15-3)as Tumor Marker for Defined Breast Cancer / I.Yokoyama et al. / p350~350
  • Postersession 83.Studies on Estrogen Receptor in Human Breast Cancer by Specific Monoclonal Antibody / S.Tsuchiya et al. / p350~350
  • Postersession 84.Evaluation of Breast Cancer-Specific Anti-Tumor Immunity by"IL-2 Enhanced MLTR" / N.Kan et al. / p350~350
  • Postersession 85.Diagnosis for Breast Disease by Pharmacological-thermography with Angiotensin II(Second Report) / Y.Hamada et al. / p351~351
  • Postersession 86.Low Field Magnetic Resonance Imaging of the Breast / K.Kanasugi et al. / p351~351
  • Postersession 87.Current Status of Diagnosis of Breast Cancer with Palpation,Mammography,Ultra-sound / K.Yoshida et al. / p351~351
  • Postersession 88.A Study on the Diagnosis and Biopsy for Breast Cancer / T.Asagoe et al. / p352~352
  • Postersession 89.Diagnostic Significance of CEA Measurement in Nipple Discharge for the Detection of Non-Palpable Breast Cancer / E.Yayoi et al. / p352~352
  • Postersession 90.MRI in Urological Cancer / K.Nishimura et al. / p352~352
  • Postersession 91.Pre-Operative Diagnosis for the Tumor Thrombus of Renal Cell Carcinoma Extended into Inferior Vena Cava / T.Shimazui et al. / p353~353
  • Postersession 92.Fine Needle Aspiration Biopsy of the Kidney and Adrenal Gland / K.Ono et al. / p353~353
  • Postersession 93.Effect of AS Vaccinia Virus for Advanced Cancer / S.Arakawa et al. / p353~353
  • Postersession 94.Interferon Therapy for Renal Cell Carcinoma / M.Suzuki et al. / p354~354
  • Postersession 95.A New Trial of Combined Chemotherapy with Tegafur,Tamoxifen,Adriamycin and Methotrexate for Advanced Clear Cell Carcinoma / T.Wada et al. / p354~354
  • Postersession 96.Examination of the Plasma Filtrated by Plasmapheresis in Terminal Stage Patients with Urogenital Malignant Tumors / Y.Ogawa et al. / p354~354
  • Postersession 97.Efficacy of Nephrectomy for Renal Cell Carcinoma with Pulmonary Metastases / S.Ichijo et al. / p355~355
  • Postersession 98.The Results of Radical Nephrectomy for Renal Cell Carcinoma / Y.Nishio et al. / p355~355
  • Postersession 99.Recurrence of Renal Cell Carcinoma after Radical Nephrectomy / T.Igarashi et al. / p355~355
  • Postersession 100.Clinical Study of Renal Cell Carcinoma / S.Miyahara et al. / p356~356
  • Postersession 101.Prognostic Evaluation in Renal Cell Carcinoma / M.Suzuki et al. / p356~356
  • Postersession 102.Clinicopathogical Factors which Affect the Survival Rates of Renal Cell Carcinoma / M.Hoshino et al. / p356~356
  • Postersession 103.Clinicostatistical Observation on Renal Cell Carcinoma / K.Yoshikawa et al. / p357~357
  • Postersession 104.Immunity of Regional Lymph Node Lymphocytes in Patients with Breast Cancer A Study of Lymphocyte Blastogenesis with PHA and PNP(Purine Nucleoside Phosphorylase)Activity / T.Takahashi et al. / p357~357
  • Postersession 105.Immune Complex and Extracorporeal Plasma Perfusion over Protein A Immobilized in Collodion Charcoal / T.Nagai et al. / p357~357
  • Postersession 106.Effect of Local Treatment with OK-432 and PSK in Recurrent Breast Cancers / M.Okazaki et al. / p358~358
  • Postersession 107.Effects of Estrogen and Prolactin on DNA-synthesizing Enzyme Activities in NMU-induced Rat Mammary Tumor / N.Kasahara et al. / p358~358
  • Postersession 108.Effect of Chemo-endocrine Therapy on DMBA-induced Mammary Carcinoma:Nuclear DNA Analysis / N.Matsunami et al. / p358~358
  • Postersession 109.Aminoglutethimide Treatment for Advanced Breast Cancer / F.Takaeko et al. / p359~359
  • Postersession 110.Prognositic Value of Hormone Receptor in Breast Cancer / H.Yamamoto et al. / p359~359
  • Postersession 111.Clinical Evaluation of Intra-arterial Infusion of Adriamycin (ADR) for Locally Advanced Breast Cancer(The 3rd Report) / T.Morimoto et al. / p359~359
  • Postersession 112.Study on Effect of Adriamycin on Advanced or Recurrent Breast Cancer(The 4th Report) / M.Izuo et al. / p360~360
  • Postersession 113.CAP Therapy (CPA,ADR,CDDP)for Advanced or Recurrent Breast Cancer--Especially for the Lymphangitic Type of Lung Metastasis / T.Yokoe et al. / p360~360
  • Postersession 114.Change of Concanavalin A-induced Suppressor Cell Activity in Breast Cancer Patients Treated with CMF Chemotherapy / N.Hagino et al. / p360~360
  • Postersession 115.The Effect of Anticancer Drugs on the Growth of Hormone Dependent Breast Cancer Cell Line, ZR-75-1 II.Anticancer Drug and Estradiol / K.Akamatsu et al. / p361~361
  • Postersession 116.Evaluation of the ATF [Low Dose Adriamycin (A)+Tamoxifen(T)+Tegafur(F)] Therapy as Adjuvant Chemotherapy for Breast Cancer / Y.Nishizawa et al. / p361~361
  • Postersession 117.Eight Year Follow-up of Adjuvant Endocrine Therapy with Mepitiostane for Operable Breast Cancer / Y.Nomura et al. / p361~361
  • Postersession 118.Establishment of Monoclonal Antibody (KEN-3) against Human Mammary Cell Line(HBC-4W) / Y.Kiyozuka et al. / p362~362
  • Postersession 119.ClinicalTrial of Bestrabucil(KM2210)in Patients with Breast Cancer / T.Yamakawa et al. / p362~362
  • Postersession 120.Clinical Evaluation of a New Oral Anti-Cancer Agent, Bestrabucil(KM2210),on Recurrent Breast Carcinoma / Y.Yamada et al. / p362~362
  • Postersession 121.Phase II Study of Bestrabucil(KM2210) on Advanced and Recurrent Breast Cancer / O.Abe et al. / p363~363
  • Postersession 122.Therapeutic Results of Recurrent Mammary Carcinoma with the Use of Bestrabucil(KM2210) / T.Ueda et al. / p363~363
  • Postersession 123.Target Oriented Anticancer Agent Bestrabucil for Long Term Treatment for Recur-rent and Far-advanced Breast Cancers / Z.Yamazaki et al. / p363~363
  • Postersession 124.A Trial of Recombinant Human Tumor Necrosis Factor Administration for Cancerous Pleural Effusion / K.Morimoto et al. / p364~364
  • Postersession 125.Internal Mammary Involvement and Estimated 5 Years Survival Rate on 120 Patients Who Underwent the Radical Mastectomy with Intrapleural en bloc Resection of Internal Mammary Lymph Node by Sternal Splitting / K.Tajiri et al. / p364~364
  • Postersession 126.Surgical Treatment for Local Recurrence of the Breast Carcinoma / H.Komoriyama et al. / p364~364
  • Postersession 127.Studies on the Quality of Life after Mastectomy / Y.Takatsuka et al. / p365~365
  • Postersession 128.Retrospective Analysis of the Treatment of Stage IIIb Breast Cancer / K.Namba et al. / p365~365
  • Postersession 129.PVB Chemotherapy on Endodermal Sinus Tumor of the Ovary / Y.Kawai et al. / p365~365
  • Postersession 130.Results of Cisplatin and Adriamycin Treatment on Malignant Ovarian Tumor and Correlation between Patients Status and Su-PS Skin Test Reaction / T.Kubota et al. / p366~366
  • Postersession 131.CDDP-ACR-CPA Combination Chemotherapy for Malignant Ovarian Tumors / N.Ushiki et al. / p366~366
  • Postersession 132.Effect of Fosfomycin (FOM) for CAP Ohemotherapy in Ovarian Cancer / A.Ikegawa et al. / p366~366
  • Postersession 133.The Protective Effect of Fosfomycin on the Nephrotoxicity in CAP Therapy for Ovarian Cancer / K.Miyasaka et al. / p367~367
  • Postersession 134.Clinical Study on Effectiveness of FCAP Chemotherapy for Ovarian Malignant Tumor / Y.Misawa et al. / p367~367
  • Postersession 135.Clinical Evaluation of Maintenance Chemotherapy with UFT for Ovarian Cancer / K.Kamioka et al. / p367~367
  • Postersession 136.Interactions of Hyperthermia and Drugs,(Adriamycin, Mitomycin C, Bleomycin,Cisplatinum) in a Human Ovarian Tumor Heterotransplanted in Nude Mice / T.Sagawa et al. / p368~368
  • Postersession 137.The Treatment of Krukenberg Tumors,Primarily by FAP Therapy / M.Tamura et al. / p368~368
  • Postersession 138.Clinical Characteristics of Serous Cystadenocarcinoma and Mucinous Cystadenocar-cinoma of the Ovary / I.Fujimoto et al. / p368~368
  • Postersession 139.Role of Laparoscopy for Early Detection of Recurrence in Cases of Post Operative Ovarian Cancer / T.Shinozuka et al. / p369~369
  • Postersession 140.Laparoscopic Follow-up of Patients with Ovarian Cancer / H.Yokota et al. / p369~369
  • Postersession 141.Clinical Study of Ovarian Cancer / T.Nakano et al. / p369~369
  • Postersession 142.A Report of Hypomagnecemia as a Result of Combination Chemotherapy Including CDDP / M.Yamanaka et al. / p370~370
  • Postersession 143.Acute Leukemia Sustained after Maintenance Chemotherapy for Ovarian Cancer--Report of a Case / T.Shimoda et al. / p370~370
  • Postersession 144.A Case of Droperidol Anesthesia in CAP Chemotherapy / Y.Sugiyama et al. / p370~370
  • Postersession 145.A Case of Ovarian Endometrioid Adenocarcinoma Being Refractory to Modern Combination Chemotherapy / T.Morita et al. / p371~371
  • Postersession 146.Cell Distribution of Each Cell Cycle Phase in Uterine Cancer / T.Sugishita et al. / p371~371
  • Postersession 147.Distribution of DNA Synthesizing Cells and Labelling Index of Cervical Cancers with Enzyme Antibody Method Using Anti-BrdU Antibody / T.Muroya et al. / p371~371
  • Postersession 148.Endometrial Adenocarcinoma and Paraaortic Lymph Node Metastasis / K.Matsukuma et al. / p372~372
  • Postersession 149.Pulmonary Metastasis of Carcinoma of the Cervix:A Clinocopathologic Study of 50 Patients / M.Imachi et al. / p372~372
  • Postersession 150.Bone Metastasis of the Carcinoma of the Uterine Cervix / K.Nakayama et al. / p372~372
  • Postersession 151.Bony Metastasis from Cervix Cancer / T.Matsuyama et al. / p373~373
  • Postersession 152.Clinico-pathologic Features of Bone Metastasis of Cancer of Uterine Cervix and Modality of Its Treatment / T.Higuchi et al. / p373~373
  • Postersession 153.A Clinicopathological Study on Bone Metastases of Cervical Carcinoma at Kure National Hospital / T.Nobunaga et al. / p373~373
  • Postersession 154.Prognosis and Therapeutic Results of Brain Metastasis in Trophoblastic Disease / K.isaka et al. / p374~374
  • Postersession 155.Pancreatic Secretory Trypsin Inhibitor (PSTI) in Gynecologic Cancer / K.Hirota et al. / p374~374
  • Postersession 156.Significance of TA-4 in the Detection of Recurrence in Cervical Squamous Cell Carcinoma / H.Morioka et al. / p374~374
  • Postersession 157.Prediction of the Recurrence of Cervical Uterine Cancer by Serum TA-4 Monitoring / T.Oishi et al. / p375~375
  • Postersession 158.Positive Ratios of Tumor Markers in Pre-Treatment Patients with Gynecological Malignant Tumor / Y.Yamane et al. / p375~375
  • Postersession 159.Studies on Multiple Tumor Markers in Patients with Carcinoma of the Uterine Cervix / M.Tanaka et al. / p375~375
  • Postersession 160.Relationship between DNA Content and Cellular Content of SCC-Ag, TPA and CEA in AMCC-1 Cultured Cells / H.Yabushita et al. / p376~376
  • Postersession 161.Change of Peripheral T Lymphocyte Subsets in Gynecologic Cancer Patients / R.Hayase et al. / p376~376
  • Postersession 162.Clinical Assesment of the Measurement of hCG Fragment in the Trophoblastic Disease / S.Imamura et al. / p376~376
  • Postersession 163.An Immunohistochemical Approach for the Radiosensitivity in Carcinoma of the Uterine Cervix / K.Fukuda et al. / p377~377
  • Postersession 164.Usefullness of Immunohistochemical Combination Assay for Differential Diagnosis of Cervical or Endometrial Adenocarcinoma / Y.Okamura et al. / p377~377
  • Postersession 165.Response to Interleukin-2 and Its Receptor in Peripheral Blood Lymphocytes of Patients with Gynecologic Malignancies / Y.Kikuchi et al. / p377~377
  • Postersession 166.Detection of Vascular Invasion on the Operative Specimen of Gastric Cancers--Evaluation of Three Staining Methods / M.Tsugita et al. / p378~378
  • Postersession 167.Distribution of Fibronectin in Gastric Cancers at Primary and Metastatic Sites / T.Kawafuchi et al. / p378~378
  • Postersession 168.A Clinicopathological Study of Gastric Cancer with Peritoneal Disseminated Metas-tasis / Y.Kato et al. / p378~378
  • Postersession 169.Not Received / /
  • Postersession 170.Tumor Markers of Gastric Cancer / H.Iwai et al. / p379~379
  • Postersession 171.Significance of Tumor Marker Measurement in Discovery of Recurrence of Stomach Cancer after Radical Operation / M.Hiramatsu et al. / p379~379
  • Postersession 172.Correlation between Tumor Associated Antigens in Gastric Cancer Tissue and Prognosis / T.Kamata et al. / p379~379
  • Postersession 173.Evaluation of Serum Neuron-Specific Enolase as a Tumor Marker for Gastrointestinal Carcinoma / N.Nakagawa et al. / p380~380
  • Postersession 174.A Study of Carbohydrate Antigen 19-9 in Tissue with Carcinomas of Human Digestive Organs / N.Tanimoto et al. / p380~380
  • Postersession 175.Localization of CEA and CA19-9 in Atypical Epithelial Lesiones and Well-Differentiated Early Cancer of the Stomach / K.Kohfuji et al. / p380~380
  • Postersession 176.Carcinoembryonic Antigen of Gastric Cancer Patients / N.Shimizu et al. / p381~381
  • Postersession 177.The of Biological Response Modifiers(BRM)on Carcinoembryonic Antigen(CEA)Level in the Serum of Gastric Cancer Patients / T.Saeki et al. / p381~381
  • Postersession 178.Changes of Killer Activity and Humoral Antibody in Cancer Patient,with Special Reference to Relationship to Stage of Diseases / H.Ubukata et al. / p381~381
  • Postersession 179.Immunohistochemical Study with Double Staining Method on Regional Lymph Nodes of Gastric Cancer / S.Chohno et al. / p382~382
  • Postersession 180.A Study of Endoscopic Ultrasonography on the Early Gastric Cancer--Determination of Depth of Cancer Invasion / M.Okubo et al. / p382~382
  • Postersession 181.A Study on TNF Production of Cultured Monocytes of Human Peripheral Blood in vitro--The Effect of OK-432 Injection for the TNF Production / T.Yamasaki et al. / p382~382
  • Postersession 182.The Effectiveness of Freeze and Dried Tumor Cells as Adding Antigen to Lymphocytes Culture / H.Watanabe et al. / p383~383
  • Postersession 183.Effects of Levamisole (LMS) on Immunity of Regional Nodes / S.Owada et al. / p383~383
  • Postersession 184.Effect of Intraperitoneal Injection of OK-432 on Patients with Carcinomatous Peritonitis--Study on Cytology and Sialic Acid in Ascites / I.Watanabe et al. / p383~383
  • Postersession 185.Clinico-pathological Characteristics on Medullary Carcinoma with Markedly Lymphoid Infiltration (MCLI) of Stomach and Clinical Application of Intratumoural Injection of OK432 / M.Mai et al. / p384~384
  • Postersession 186.Randomized Controlled Study of Post Operative Gastric Cancer Chemotherapy--Comparison with Mifurol and Tegafur / H.Sato et al. / p384~384
  • Postersession 187.A Prospective Randomized Trial Comparing AF versus FAM in Advanced Gastric Cancer--The Second Study of a Cooperative Study Group / T. Yokomori et al. / p384~384
  • Postersession 188.Effectiveness of Postoperative Immunochemotherapy on stage IV Gastric Cancer / Y.Akamo et al. / p385~385
  • Postersession 189.A Sequential Study of Adjuvant Immunochemotherapy for Gastric Cancer after Gastrectomy / K.Yoshinaka et al. / p385~385
  • Postersession 190.A Multi-institutional Study on Postoperative Adjuvant Immunochemotherapy for Gastric Cancer / T.Nakajima et al. / p385~385
  • Postersession 191.A Study of Surgical Adjuvant Immunochemotherapy for Gastric Cancer The specific Study (1) [II]-Three-year-Survival- / Y.Nakanishi et al. / p386~386
  • Postersession 192.Protocol Practice Supported by a Computer-Based Medical-Record System / K Akazawa et al. / p386~386
  • Postersession 193.Intra-Arterial Infusion Therapy with Angiotensin-II for Patients with Advanced and Recurrent Cancer of Stomach / N.Takahashi et al. / p386~386
  • Postersession 194.Intraaortic Infusion Therapy with Sequential Methotrexate (MTX) and 5-FU for Advanced Gastric Carcinoma / M.Kitamura et al. / p387~387
  • Postersession 195.Constant Intra-arterial Infusion Chemotherapy for the Patients with Gastric Cancer Who Had Intraabdominal Metastases / M.Sato et al. / p387~387
  • Postersession 196.Experimental Studies of Endoscopic Local Hyperthermia with Low Power Nd-YAG Laser Irradiation by Using Frosted Probe / J.Aoki et al. / p387~387
  • Postersession 197.Treatment of Advanced Gastric Cancer with Local Radiofrequency Hyperthermia and Continuous Hyperthermic Peritoneal Perfusion / Y.Yonemura et al. / p388~388
  • Postersession 198.Not Received / /
  • Postersession 199.The Effect of Preoperative Irradiation Therapy in Advanced Stomach Cancer with Special Reference to Histopathological Changes of Metastatic Lymph Nodes / Y.Goto et al. / p388~388
  • Postersession 200.Intraoperative Local Injection of Fine Particles of Activated Charcoal Applied for Lymph Nodes Dissection of Gastrointestinal Cancers / T.Yamaguchi et al. / p388~388
  • Postersession 201.Evaluation of Gastric Cancer Resected Palliatively because of Liver Metastasis / T.Nakadate et al. / p389~389
  • Postersession 202.Investigation of the Gastric Cancer with Bone Metastasis / H.Horichi et al. / p389~389
  • Postersession 203.Study on Gastric Squamous Cell and Adenosquamous Cell Carcinomas / H.Ishibashi et al. / p389~389
  • Postersession 204.Not Received / /
  • Postersession 205.Tamoxifen-induced Growth Inhibition to Cultured Human Gastric Cancer Cells and Tamoxifen Binding Fraction in Cancer Cell / H.Ohkura et al. / p390~390
  • Postersession 206.The Antitumor Effects of Human Fibroblast Interferon(IFN-β)and 5-FU on Human Gastric Cancers Xenografts in Nude Mice / K.Mitsuda et al. / p390~390
  • Postersession 207.Chemotherapy Responsiveness of Human Gastric Cancer Implanted in Subrenal Capsules of Nude Mice / M.Yamauchi et al. / p390~390
  • Postersession 208.Effectiveness of the Adriamycin-Almineum(ADR-Al)Complex upon the Human Gastric Cancer Transplanted to Nude Mice / M.Tanaka et al. / p391~391
  • Postersession 209.Changes of Plasma Concentration of 5-Fluorouracil in Long Term Oral Administration / M.Fujii et al. / p391~391
  • Postersession 210.Study on the Correlation between Tissue Uptakes of Tegafur and Prognosis / S.Arima et al. / p391~391
  • Postersession 211.Anticancer Drug Distribution to Lymph and Blood in Adjuvant Chemotherapy after Surgery for Gastric Carcinoma--A Study with Combined Preparation of 1-(2-Tetrahydrofuryl)-5-Fluorouracil and Uracil / H.Hanaue et al. / p392~392
  • Postersession 212.Evaluation of Continuous Drip Infusion of Tegaful with Intravenous Hyperalimenta-tion before and after Surgery in Gastric Cancer Patients / A.Hizuta et al. / p392~392
  • Postersession 213.UFT+MMC and UFT+ACNU Therapy on Advanced Gastric Cancer / T.Sasai et al. / p392~392
  • Postersession 214.Clinical Usefulness of UFT-M-O Therapy for Advanced Gastro-intestinal Cancer / S.Misawa et al. / p393~393
  • Postersession 215.The Combination Chemotherapy of Epirubicin,Mitomycin C and 5-Fluorouracil(FEM) against Inoperable Gastric Cancer / T.Kimura et al. / p393~393
  • Postersession 216.The Effects of PMU Therapy for Advanced Gastric Cancer / N.Matsuki et al. / p393~393
  • Postersession 217.Combination Chemotherapy of UFT(F),Etopside(E)and CDDP(P)in Advanced Gastric Cancer / M.Hayakawa et al. / p394~394
  • Postersession 218.Effects of Cis-dichlorodiammineplatinum(CDDP)in Advanced Gastro-intestinal Tract Cancer--Application for Pre-and Post-operative Chemotherapy / S.Saji et al. / p394~394
  • Postersession 219.Effects of Cis-platinum(CDDP)for Recurrent Cancer of the Stomach and the Colon / A.Kadowaki et al. / p394~394
  • Postersession 220.Methotrexate(MTX)and 5-Fluorouracil(5FU with Leucovorin(LV)Therapy for Advanced Gastric Cancer / I.Sugiura et al. / p395~395
  • Postersession 221.Chemosensitive Oriented Therapy(COT)for Unresectable Gastric Cancer with Peritoneal Disseminations / Y.Hiramoto et al. / p395~395
  • Postersession 222.Evaluation of Antitumor Efficacy by Polyamine Antimetabolites in Combination with DNA Attacking Anticancer Drugs / R.D. Shrestha et al. / p395~395
  • Postersession 223.Pharmakokinetics of Cisplatin in Patients with Chronic Renal Failure / M.Miyakawa et al. / p396~396
  • Postersession 224.Study on a Survival Time of Gastric Cancer Patients Using Multivariate Analyses / M.Sawai et al. / p396~396
  • Postersession 225.Prognostic Factors of Primary Gastric Cancer,Univariate and Multivariate Analyses of 4,734 Resected Cases / K.Maruyama et al. / p396~396
  • Postersession 226.Quality of Life after Surgical Treatment of Gastric Cancer / T.Kuroda et al. / p397~397
  • Postersession 227.Multidisciplinary Treatment for a Case of Recurrent Peritoneal Dissemination with Massive Omental Tumor / H.Ueda et al. / p397~397
  • Postersession 228.Cronkhite-Canada Syndrome Associated with Cancer / A.Goto et al. / p397~397
  • Postersession 229.A Study of Gastric Cancer with Multiple Primary Carcinoma(MPC) / H.Motohashi et al. / p398~398
  • Postersession 230.The Case Report in Which IgE Was Seen to be Absorbed in the Gastric Cancerous Tissue by Immuno-peroxidase Method / T.Fujii et al. / p398~398
  • Postersession 231.Specific of Monoclonal Antibody,A7,against Human Colorectal Cancers and Possibil-ity of Missile Therapy / H.Suzuyama et al. / p398~398
  • Postersession 232.Tissue Localization of Endogenous Sex Hormones in Colorectal Cancer Tissues / Y.Uehara et al. / p399~399
  • Postersession 233.Chemosensitivity of Human Colorectal Cancer Xenografted In Nude Mice / K.Yamada et al. / p399~399
  • Postersession 234.Effect of a Combination of UFT and MMC(UFT-M)on Colonic Cancer Xenotrans-planted in Nude Mice / Y.Takahashi et al. / p399~399
  • Postersession 235.Anti-Cancer Treatment with Prostaglandin Synthetase Inhibitor Indomethacin / M.Takahashi et al. / p400~400
  • Postersession 236.Adjuvant Immuno-chemotherapy of Colorectal Cancer with MMC,Tegafur and PSK / T.Tominaga et al. / p400~400
  • Postersession 237.Multidisciplinary Treatment for Advanced Colorectal Cancer with Long Term Continuous i.v. Infusion of 5FU / H.Kida et al. / p400~400
  • Postersession 238.A Randomized Controlled Study on Adjuvant Chemotherapy with Mitomycin C and HCFU in Noncuratively Resected Colorectal Cancer Patients / M.Niimoto et al. / p401~401
  • Postersession 239.Transcatheter Arterial Chemoembolization for the Alimentary Tract--A Trial in the Colorectal Cancers / K.Mieno et al. / p401~401
  • Postersession 240.PDT in Recurrent Rectal Carcinoma Using a Pulsed Gold Vapour Laser / K.Kato et al. / p401~401
  • Postersession 241.Clinical and Pathological Studies of Cases Undergoing Curative Operation for Rectal Cancer (Comparison between Poor Prognostic Group and Long Survival Group) / Y.Kuzawa et al. / p402~402
  • Postersession 242.A Young Case with Colon Cancer Detected at Emergency Operation and Study of Young Cases with Colon Cancer / T.Yamanaka et al. / p402~402
  • Postersession 243.Comparison Study of Histological Classification of Non-Hodgkin′s Lymphoma / M.Kita et al. / p402~402
  • Postersession 244.Immunosuppressive Acidic Protein(IAP)in the Patients with Hematological Malig-nancy / S.Hayashi et al. / p403~403
  • Postersession 245.Thymidylate Synthetase and Thymidine Kinase Activities in Bone Marrow Cells of Leukemias / H.Kudo et al. / p403~403
  • Postersession 246.Radiotherapy for Adult T-cell Leukemia / Y.Baba et al. / p403~403
  • Postersession 247.Treatment Results from Radiation Therapy to Non-Hodgkin Lymphomas in Head and Neck Region / K.Sakata et al. / p404~404
  • Postersession 248.Drug Sensitivity Test on Leukemic Blast Progenitors / Y.Asano et al. / p404~404
  • Postersession 249.Cisplatin-ACNU Therapy for Non-Hodgkin′s Lymphoma / Y.Araki et al. / p404~404
  • Postersession 250.A New Combination Chemotherapy for Non-Hodgkin's Lymphoma / C.Konda et al. / p405~405
  • Postersession 251.Not Received / /
  • Postersession 252.Effects of Adriamycin on Lymphocyte Subsets and Lymphocyte Functions in vitro / Y.Suzuki et al. / p405~405
  • Postersession 253.The Combination of Aclarubicin (ACR),Vincristine(V),Cyclophosphamide(C),and Prednisolone(P),(ACR-VCP)in the Treatment of Multiple Myeloma / K.Izumi et al. / p405~405
  • Postersession 254.Stage I and II Non-Hodgikin′s Lymphomas of the Head and Neck:The Working Formulation is of Value for Predicting Outhome / N.Shigematsu et al. / p406~406
  • Postersession 255.Clinical Trial of MCNU Tablets on Hematological Malignancies / I.Tanaka et al. / p406~406
  • Postersession 256.Clinical Effects of TA-077 in Non-Hodgkin's Lymphomas / T.Kobayashi et al. / p406~406
  • Postersession 257.Clinical Trial of SM-108 on the Myeloproliferative Syndromes / M.Nishikawa et al. / p407~407
  • Postersession 258.Not Received / /
  • Postersession 259.Treatment of Disseminated Intravascular Coagulation(DIC)with Gabexate Mesilate(FOY)in Malignant Disease / H.Wada et al. / p407~407
  • Postersession 260.Mechanism of Brain Metastasis
  • Correlation with Cerebrovascular Disease / Y.Tokuriki et al. / p407~407
  • Postersession 261.Basic Research of Treatment with Protease Inhibitor for Meningeal Gliomatosis / C.Obonai et al. / p408~408
  • Postersession 262.Long-Term Effects of Cranial Irradiation and Chemotherapy on Hemocirculation and Metabolism of Brain Tissue in Patients with Brain Tumors / K.Mineura et al. / p408~408
  • Postersession 263.Radiation Therapy of Pontine Glioma / Y.Aoki et al. / p408~408
  • Postersession 264.Radiotherapy for Pineal Region Tumors / S.Nishino et al. / p409~409
  • Postersession 265.Proton Radiation Therapy for Brain Tumors / Y.Yoshii et al. / p409~409
  • Postersession 266.Analysis of Relapse after Postoperative Irradiation at Astrocytoma Grade II-IV / K.Nishikawa et al. / p409~409
  • Postersession 267.Results of Radiation Therapy for Brain Metastases / M.Kataoka et al. / p410~410
  • Postersession 268.Effect of ACNU on Cell Proliferation of Experimental Brain Tumor / S.Izumoto et al. / p410~410
  • Postersession 269.Inhibitory Effect of A¹²-prostaglandin J₂ on Rat Brain Tumor and Rat NK Activity / H.Matsuura et al. / p410~410
  • Postersession 270.Chemotherapy with Nitrosoureas and UFT against Malignant Brain Tumors / H.Okamoto et al. / p411~411
  • Postersession 271.Adjuvant Chemotherapy for Brain Tumors / M.Ito et al. / p411~411
  • Postersession 272.Investigation for Clinical Trial of Brain Heating by Magnator NK / M.Ohta et al. / p411~411
  • Postersession 273.Anti-tumor Effect of Human Recombinant TNF(PT-050)on a Tumor Line of Human AFP Producing Immature Teratoma / K.Kurisu et al. / p412~412
  • Postersession 274.Induction of LAK Cells from Splenocytes or Thymocytes in Normal and 9L-Glioma Bearing Rat / H.Imaya et al. / p412~412
  • Postersession 275.Not Received / /
  • Postersession 276.Cbservations on the Local Administration of Autologous Lymphokine Activated Killer Cells and Recombinant Interleukin-2 to Patients with Malignant Gliomas / S.Yoshida et al. / p412~412
  • Postersession 277.Not Received / /
  • Postersession 278.Sister Chromatid Exchange as a Measure of Tumor Cell and Normal Cell(Lymphocyte)Sensitivities to ACNU / S.Kobayashi et al. / p413~413
  • Postersession 279.Malignant Lymphoma Initially Involved of the Brain (Experience of 10 cases) / Y.Tamaki et al. / p413~413
  • Postersession 280.Treatment Results of Cerebral Differentiated Gliomas in Adults / M.Matsutani et al. / p413~413
  • Postersession 281.Observations of Adenocarcinoma of the Prostate According to the Criteria of Gleason′s Score : Clinicopathological Assesment of 93 Cases / H.Kusuyama et al. / p414~414
  • Postersession 282.Clinicopathological Study of Prostatic Cancer(Part 3) / Y.Furukawa et al. / p414~414
  • Postersession 283.A Comparative Study with the Cases of Transitional Cell Carcinoma of the Prostate and the Cases with Prostatic Involvement of Transitional Cell Carcinoma of the Urinary Bladder / K.Takai et al. / p414~414
  • Postersession 284.Clinical Evaluation of Measurement of Multiple Markers in Prostate Cancer / I.Shinoda et al. / p415~415
  • Postersession 285.Usefulness of PAP,Y-Sm and PA as Markers for Prostatic Cancer / T.Akagi et al. / p415~415
  • Postersession 286.Relationship between Relapse and Tumor Markers in Prostatic Cancer / H.Fuse et al. / p415~415
  • Postersession 287.Intraoperative Radiotherapy for Carcinoma of the Prostate / S.Kojima et al. / p416~416
  • Postersession 288.Proton Therapy for Genitourinary Cancer / S.Nemoto et al. / p416~416
  • Postersession 289.Radiation Therapy for Localized Prostatic Cancer / H.Suto et al. / p416~416
  • Postersession 290.Pelvic Lymphadenectomy before Radiotherapy for Prostatic Carcinoma / T.Takeda et al. / p417~417
  • Postersession 291.Chemotherapy of Antiandorogenic Therapy Resistant Prostate Cancer / M.Takeda et al. / p417~417
  • Postersession 292.Treatment of stage D Prostatic Cancer Patients with Hormones in Combination with Cyclophosphamide / I.Nakamura et al. / p417~417
  • Postersession 293.Cheme-hormonal Therapy in the Untreated Patients with Poorly Differentiated Adenocarcinoma of the Prostate at stage D / J.Yoshimoto et al. / p418~418
  • Postersession 294.Attempt of Preoperative Stage Down Chemotherapy against Prostatic Cancer / M.Yuasa et al. / p418~418
  • Postersession 295.Etoposide Therapy for the Prostatic Cancer / M.Maruoka et al. / p418~418
  • Postersession 296.Experience with an LH-RH Agonist in the Treatment of Prostatic Cancer--Monitoring of Tumor Markers(γ-Seminoprotein,Prostate Specific Antigen,Pros-tatic Acid Phosphatase) / Y.Tada et al. / p419~419
  • Postersession 297.Clinical Response and Safety of Buserelin(LH-RH Agonist)Treatment in Prostatic Cancer / Y.Ishii et al. / p419~419
  • Postersession 298.Clinical Efficacy of LHRH Analogue(Buserelin)in Advanced Carcinoma of Prostate / K.Suzuki et al. / p419~419
  • Postersession 299.Treatment of Prostatic Cancer with LH-RH Analog / J.Shimazaki et al. / p420~420
  • Postersession 300.Effects of Gonadotropin-Releasing Hormone Analogues(LH.RH Analogues) on the Untreated Prostatic Carcinoma / H.Akaza et al. / p420~420
  • Postersession 301.Clinical Significance of Radical Prostatectomy and Nerve Sparing Radical Pros-tatectomy / K.Okada et al. / p420~420
  • Postersession 302.A Mass Screening of Prostatic Cancer in Nagasaki City / Y.Minami et al. / p421~421
  • Postersession 303.Factors Affecting Survival in the Patients with Prostatic Carcinoma / M.Hiramori et al. / p421~421
  • Postersession 304.Surgical Treatment of Plantar Palmer Subungual Melanoma / T.Tomita et al. / p421~421
  • Postersession 305.Treatment of Malignant Melanoma with HuIFN-β Given Preoperatively by Local Injection / A.Yamamoto et al. / p422~422
  • Postersession 306.Clinical Evaluation of Radioisotopes(⁶⁷Ga-citrate,⁹⁹mTc,²⁰¹Tl-chloride) in the Diagnosis of Soft Part Tumors / Y.Beppu et al. / p422~422
  • Postersession 307.Evaluation of Chemotherapy of Malignant Soft Part Tumors by Nuclear Magnetic Resonance / Y.Shimomura et al. / p422~422
  • Postersession 308.Adjuvant Chemotherapy for Patients with Soft Tissue Sarcomas of Extremities / Y.Ogihara et al. / p423~423
  • Postersession 309.Preoperative Intra-arterial Infusion Chemotherapy for Soft Tissue Sarcomas / T.Ueda et al. / p423~423
  • Postersession 310.4 Cases of Malignant Lymphomas Manifested Surface Tumor / M.Ishikura et al. / p423~423
  • Postersession 311.Infantile Fibrosarcoma / Y.Hatae et al. / p424~424
  • Postersession 312.Clinical Behavior and Follow-up Results of 28 Patients with Neurosarcoma / I.Sugiura et al. / p424~424
  • Postersession 313.Prognostic Factor of Soft Tissue Sarcomas / H.Bun et al. / p424~424
  • Postersession 314.S-100 Protein Immunostaining in the Differential Diagnosis of Bone Tumors and Tumorous Conditions / K.Okajima et al. / p425~425
  • Postersession 315.Not Received / /
  • Postersession 316.Immunomodulating Effect of Gamma Interferon on Human Osteosarcoma Cell Lines / J.Toguchida et al. / p425~425
  • Postersession 317.The Anti-Tumor Effect of Vitamin D3 on Dunn Osteosarcoma / K.Hara et al. / p425~425
  • Postersession 318.DNA-RNA Cytofluorometric Analysis of the Effect of Adriamycin, Cis-Diammine-dichloroplatinum(II)and Methotrexate on Dunn Osteosarcoma in vivo / S.Nakamura et al. / p426~426
  • Postersession 319.Evaluation of Efficacy of Chemotherapeutic Agents on Transplantable Spontaneous and 4-HAQO Induced Osteosarcoma in Rats / Y.Miyauchi et al. / p426~426
  • Postersession 320.Cytofluorometric Evaluation of the Effect of the Preoperative Chemotherapy on the Malignant Bone and Soft Tissue Tumors / K.Kusuzaki et al. / p426~426
  • Postersession 321.The Sensitivity Test of Anti-cancer Agent for Malignant Bone and Soft Tissue Sarcomas / H.Fukushima et al. / p427~427
  • Postersession 322.Tc Bone Scintigram of Axial Skeleton in Cancer Patients, Referring to the Initial Diagnosis to Recongition of Abnormal Uptake, and Prognosis / S.Morishita et al. / p427~427
  • Postersession 323.Staging of Metastatic Bone Disease / K.Yamashita et al. / p427~427
  • Postersession 324.Natural History of Mucosal Hyperplasia and Dysplasia which Obtained from the Spe-cimen of Multiple Cold-cup Biopsy in Normal-looking Mucosa with Superficial Bladder Cancer / K.Uchida et al. / p428~428
  • Postersession 325.Relationship between Endoscopic Nontumorous Mucosal Changes and Flat Path-ological Lesions in Patients with Urinary Bladder Carcinoma / M.Wajiki et al. / p428~428
  • Postersession 326.A Study on Measurement of Urinary Fibronectin / S.Nakatsuka et al. / p428~428
  • Postersession 327.Evaluation on Responder's Check to Non-specific Immunotherapy in Cancer-Bearing Hosts / Y.Nakagami et al. / p429~429
  • Postersession 328.Therapeutic Intravesical Instillation of BCG in the Management of Bladder Tumors / S.Jitsukawa et al. / p429~429
  • Postersession 329.Intravesical BCG Therapy for Bladder Tumors / M.Murayama et al. / p429~429
  • Postersession 330.Intravesical Bacillus Galmette-Guerin in the Treatment of Recurrent Superficial Bladder Tumors / M.Nakano et al. / p430~430
  • Postersession 331.Histological Changes in Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer and Normal Epithelia / T.Kogawa et al. / p430~430
  • Postersession 332.Experience of Intralesional Injection of Recobinant IL-2 in Bladder Cancer / T.Fujioka et al. / p430~430
  • Postersession 333.Intravesical Administration of GKT-β for Bladder Cancer / Y.Matsumura et al. / p431~431
  • Postersession 334.The Effect of LC-9018 on Human Bladder Cancer / E.Karasawa et al. / p431~431
  • Postersession 335. Tissue Concentration and Infiltration to Tumor Tissue of Adriamycin and (2")R-4′- O-Tetrahydrophyranyladriamycin in Intravesical Instillation for Rat Bladder Tumors by BBN / H. Masuda et al. / p431~431
  • Postersession 336. Effect of Continuous Intravesical Instillation of Mitomycin-C on the Development of N-butyl-N-4-hydroxybutyl-nitrosamine (BBN) Induced Rat Bladder Tumor / S. Kawano et al. / p432~432
  • Postersession 337. Intravesical Instillation Therapy of Peplomycin and Cytosine Arabinoside for Bladder Tumor Comparison with Mitomycin C or Adriamycin / N. Kinoshita et al. / p432~432
  • Postersession 338. Sequential Instillation Therapy with Mitomycin-C and Adriamycin for Superficial Bladder Cancer / I. Fukui et al. / p432~432
  • Postersession 339. The Serum Concentration of Adriamycin Intravesically Instillated Immediately after the TUR-Bt / T. Akiya et al. / p433~433
  • Postersession 340. Comparison of the Various Immunosuppressive Drugs in Subrenal Capsular (SRC) Assay--Using FANFT Induced Mouse Bladder Tumor (MBT-2) / H. Mitsui et al. / p433~433
  • Postersession 341. Preliminary Study of Flow Cytometric DNA/Bromodeoxyuridine (Brdu) Analysis with the Aim of Application to Drug-Sensitivity Test / T. Shimabukuro et al. / p433~433
  • Postersession 342. Study of the Change in Chemosensitivity during Chemotherapy for Uroepithelial Cancers / H. Kanamaru et al. / p434~434
  • Postersession 343. Enzymuria Following CDDP Administration : Difference in Increase Pattern of Urinary Activities between NAG and γ-GTP / T. Takahashi et al. / p434~434
  • Postersession 344. Platinum Distribution and Concentration in the Human Tissue after Administration of Cisplatin / T. Tochigi et al. / p434~434
  • Postersession 345. Blood and Tissue Concentration of HCFU and 5-FU in Oral Administration of HCFU to Bladder Tumor Patients / M. Ohinata et al. / p435~435
  • Postersession 346. The Combination Chemotherapy with Cyclophosphamide, Adriamycin, and Cis-plati-num in Advanced Urothelial Tumor / Y. Tanaka et al. / p435~435
  • Postersession 347. Chemotherapy of Advanced Urinary Bladder Cancer / Y. Kubota et al. / p435~435
  • Postersession 348. Not Received / /
  • Postersession 349. Prognosis after Surgical Treatment of Pulmonary Metastases of Osteosarcomas / H. Yoshikawa et al. / p436~436
  • Postersession 350. Surgical Treatment of Bone Tumor Metastasized in the Lung--Indication and Mode of Operation / A. Koyama et al. / p436~435
  • Postersession 351. The Treatment of Metaststic Carcinoma of Extremities Using External Fixation / Y. Hamada et al. / p436~436
  • Postersession 352. 2 Cases of Total Femur Replacement for Cancer Patients / K. Hirohata et al. / p437~437
  • Postersession 353. Surgical Treatment for Metastatic Bone Tumors of the Lower Extremity / K. Suzuki et al. / p437~437
  • Postersession 354. Surgical Treatment for Metastatic Bone Tumor of Limb and Pelvis / A. Suda et al. / p437~437
  • Postersession 355. Treatment of the Metastatic Carcinoma of the Spine / K. Mochizuki et al. / p438~438
  • Postersession 356. Possible Use of Boron Neutron Capture Therapy in Limb Preservation in Dogs with Osteosarcoma / A. Takeuchi et al. / p438~438
  • Postersession 357. Total Femur Replacement for Osteosarcoma of the Femur A Case Report / N. Miyake et al. / p438~438
  • Postersession 358. Tumor Prosthesis after Wide Resection for Osteosarcoma / A. Uchida et al. / p439~439
  • Postersession 359. Limb Salvage Procedures for Malignant Bone Tumors of the Extremities, with Special Reference of the Verious Reconstructive Procedures for the Defect of Bone / T. Morita et al. / p439~439
  • Postersession 360. Reconstruction of Malignant Bone Tumor by Composite Graft of Biomaterial / K. Shinjo et al. / p439~439
  • Postersession 361. Chondrosarcoma of the Ribs : Treatment of 5 Cases / H. Yahagi et al. / p440~440
  • Postersession 362. Giant Cell Tumor of Bone A Clinicopathologic and Cytophotometric Study of 28 Cases / M. Ushijima et al. / p440~440
  • Postersession 363. Clinical Study of Sacrococcygeal Chordoma : A Report of twelve Cases / M. Yamanashi et al. / p440~440
  • Postersession 364. Radioimmunodetection of Neuroblastoma with Anti-neuroblastoma Monoclonal Antibody / T. Etoh et al. / p441~441
  • Postersession 365. Verapamil Enhancement of Antitumor Effect of Cis-diamminedichloroplatinum (II) in Nude Mouse-grown Human Neuroblastoma / H. Ikeda et al. / p441~441
  • Postersession 366. Chemotherapy for Advanceed Neuroblastoma / K. Shimizu et al. / p441~441
  • Postersession 367. Aggressive Treatment of Neuroblastoma in Advanced Stage / T. Takeda et al. / p442~442
  • Postersession 368. An Evaluation of Chemotherapy by Means of Balloon Occluded Arterial Infusion (BOAI) to Advanced Gynecological Cancer / H. Takahashi et al. / p442~442
  • Postersession 369. Thermotherapy for the Gynecological Malignant Tumors, Particularly Combined Effects with Radio-or Chemotherapy / Y. Kobashi et al. / p442~442
  • Postersession 370. A Case of Hyperthermia (Inductive Aperture-Type Applicator) for Skin Metastasis of Endometrial Cancer / S. Kijima et al. / p443~443
  • Postersession 371. An Evaluation of Operative Cases of Endometrial Cancer / M. Ikeuchi et al. / p443~443
  • Postersession 372. Clinical and Histological Study on the Tissue Repair after Conization / M. Nagahara et al. / p443~443
  • Postersession 373. Conization by CO2 Laser in the Uterine Cervix / Y. Okuma et al. / p444~444
  • Postersession 374. Carbon Dioxide Laser Conization for Cervical Intraepithelial Neoplasia / M. Moriyama et al. / p444~444
  • Postersession 375. Long-term Follow-up Studies on the Treatment of CIN by CO₂ Laser Vaporization / K. Yonagida et al. / p444~444
  • Postersession 376. Urological Complications Following Radical and Extended Hysterectomy for Uterine Cancer / M. Matsuzawa et al. / p445~445
  • Postersession 377. In Radical Hysterectomy Employing Ultrasonic Aspiration Technique, the Pelvic Nerve was Well Preserved / I. Matsunaga et al. / p445~445
  • Postersession 378. The Role of Thoracotomy for Metastatic Choriocarcinoma / M. Matsumura et al. / p445~445
  • Postersession 379. Clinico-pathological Analysis of stage IIIa Carcinoma of the Cervixuteri / A. Takano et al. / p446~446
  • Postersession 380. Clinico-pathological Study on Endometrial Carcinoma--The Factors Influencing the Prognosis / T. Akahori et al. / p446~446
  • Postersession 381. Clinicopathologic Study on Carcinoma of Uterine Body / K. Shiromizu et al. / p446~446
  • Postersession 382. 12 Cases with Primary Carcinoma of the Fallopian Tube / Y. Nakai et al. / p447~447
  • Postersession 383. Pelvic Exenteration : 5 Cases Experience / S. Hino et al. / p447~447
  • Postersession 384. A Case Report of Uterine Carcinosarcoma with Alfa-Fetoprotein (AFP) Production / K. Shigemasa et al. / p447~447
  • Postersession 385. Remission of Cerebral Metastasis of Choriocarcinoma Followed by Normal Pregnancy and Delivery / H. Yokota et al. / p448~448
  • Postersession 386. Studies on Late Recurrence of the Carcinoma of Uterin Cervix in Osaka National Hospital / T. Shibamoto et al. / p448~448
  • Postersession 387. A Preliminary Result of Radiation plus Hydroxyurea for Glassy Cell Carcinoma of the Uterine Cervix / D. Hori et al. / p448~448
  • Postersession 388. Chemotherapy for Squamous Cell Carcinoma of the Uterine Cervix A Study of in vivo Chemosensitivity Test in Nude Mice / M. Kawabata et al. / p449~449
  • Postersession 389. Response Indicator of Chemo-endocrine Therapy for Endometrial Cancer by Colony-forming Assay / J. Fujimoto et al. / p449~449
  • Postersession 390. The Determination of Thymidylate Tynthetase Inhibition for Testing Fluoro- pyrimidines / K. Sakakibara et al. / p449~449
  • Postersession 391. High Dose Chemotherapy for Gynecological Malignancy in A Bioclean Room / S. Matsuura et al. / p450~450
  • Postersession 392. The Effect of the Combination Chemotherapy with CDDP, Vinblastin and Pe- pleomycin on the Advanced or Recurrenced Gynecological Malignancies / Y. Onishi et al. / p450~450
  • Postersession 393. Experimental Studies for the Antitumor Effect of Oral Antitumor Agents on Gyne- cological Malignant Tumors / I. Sekiguchi et al. / p450~450
  • Postersession 394. Importance of Bestatin Therapy for Trophoblastic Disease (T. B. D) / A. Yamamoto et al. / p451~451
  • Postersession 395. Multimodal Treatment of Advanced Gynecological Cancers Including 4'-O-Tetrahy- dropyranyl-Adriamycin (THP-ADM) Chemotherapy / M. Hiroo et al. / p451~451
  • Postersession 396. Evaluation of Oral-adjuvant Chemotherapy for Post-operative Uterine Cervical Cancer and It′s Estimated Prognosis Curve / S. Okamura et al. / p451~451
  • Postersession 397. Study of Postoperative Therapy for Carcinoma of the Cervix (Comparison between BM, MOP Therapy and External Radiation) / K. Yoshida et al. / p452~452
  • Postersession 398. Pharmacologic and Therapic Studies of Continuous Subcutanuous Infusion of Pe- plomycin in Patients with Cancer of the Cervix Uteri / H. Asai et al. / p452~452
  • Postersession 399. Combination Chemotherapy with Cisplatin, Doxorubicin and Cyclophosphamide (CAP) for Recurrent Endometrial Cancer / S. Baba et al. / p452~452
  • Postersession 400. Intraarterial Chemotherapy with Cis-platinum and Adriamycin in Advanced Car-cinoma of the Uterine Cervix / T. Tsujii et al. / p453~453
  • Postersession 401. Evaluation of Antitumor Effect of Cisplatin to Carcinoma of the Uterine Cervix / O. Nakamoto et al. / p453~453
  • Postersession 402. Intra-arterial Infusion of Cisplatin for Stage III and IV Cervical Cancer / K. Miyazaki et al. / p453~453
  • Postersession 403. Selective Intra-arterial Administration of High Dose of CDDP in Combination Plasmapheresis / I. Tateyama et al. / p454~454
  • Postersession 404. A Study on Blood Flow with a Intraarterial Digital Subtraction Angiographic Method in Hypertension Chemotherapy Induced by Angiotensin II for Advanced Uterine Cervical Cancer / O. Iwanari et al. / p454~454
  • Postersession 405. Not Received / /
  • Postersession 406. Intra-Arterial Infusion Chemotherapy with Adriamycin for the Treatment of Uterin Cervical Cancer / H. Taniguchi et al. / p454~454
  • Postersession 407. Treatment of Advanced or Recurrent Uterine Cervical Cancer with Balloon Occlude Arterial Infusion / M. Kawabata et al. / p455~455
  • Postersession 408. Preoperative Evaluation of Localy Recurrent Uterine Cervical Cancer / K. Inafuku et al. / p455~455
  • Postersession 409. Significance of a CT SCAN after the Cure of a Gynecological Malignant Tumor (Especially on the Early Diagnosis of Lymphonodal Recurrence) / M. Tsuruoka et al. / p455~455
  • Postersession 410. Approach to the Fine Angioarchitecture of the Uterine Cervical Adenocarcinoma 3rd Report: Adenoma Maligunum and Poorly Differrentiated Adenocarcinoma / K. Yamashita et al. / p456~456
  • Postersession 411. Cytologic Study on Endocervical Lesions Using " Cytobrush " / T. Hasegawa et al. / p456~456
  • Postersession 412. Asymptomatic Endometrial Cancer at Cancer Institute Hospital / K. Yamauchi et al. / p456~456
  • Postersession 413. Screening Method to Detect Early Carcinoma of the Endometrium / T. Jobo et al. / p457~457
  • Postersession 414. Hysteroscopic Observation of Precancerous Lesions and Early Cancers of Endometrium / E. Takashima et al. / p457~457
  • Postersession 415. Correlation of Dose-volume Curve and Late Complication of the Rectum in the Uterine Cervix / J. Mizoe et al. / p457~457
  • Postersession 416. Conformation Radiotherapy for the Intrapelvic Lesions / T. Shimizu et al. / p458~458
  • Postersession 417. Radiotherapy with Interstitial Implantation for Female Pelvic Tumors / A. Takamura et al. / p458~458
  • Postersession 418. Radio-thermo Therapy against Radioresistant Factors of Uterine Adenocarcinoma / H. Sasaki et al. / p458~458
  • Postersession 419. Radiotherapy for Uterine Cervical Cancer / N. Mitsuhashi et al. / p459~459
  • Postersession 420. A Study of Proton Beam Therapy for the Patients with Carcinoma of Uterine Cervix / M. Kaneko et al. / p459~459
  • Postersession 421. Not Received / /
  • Postersession 422. Protection of Parametritis Using Latamoxef after Lymphnodectomy / A. Yakabe et al. / p459~459
  • Postersession 423. Clinical Evaluation of Immunopotentiators for Advanced Cervical Cancer--Study on Cases of stage III Cervical Caner with Radical Surgery after Preoperative Irradiation / K. Hasegawa et al. / p460~460
  • Postersession 424. γ-Interferon Treatment on Cervical Intraepithelial Neoplasia / T. Iwasaka et al. / p460~460
  • Postersession 425. Investigation of Antitumor Activity and Prognosis in Patients with Cervical Carcinoma Administered BRM (Biological Response Modifier) Preoperatively / K. Wakida et al. / p460~460
  • Postersession 426. Effect of Recombinant Interleukin 2 on in vitro Autologous Tumor Cell Killing Activity of Gynecological Cancer Patients / Y. Kanaoka et al. / p461~461
  • Postersession 427. Evaluation of Prostaglandin Inhibitor in the Cancer Immunotherapy of OK-432 / Y. Ohshika et al. / p461~461
  • Postersession 428. Not Received / /
  • Postersession 429. Correlation of Cytological Grading and Pattern Grading with Prognosis of Ovarian Malignancies / M. Nakayama et al. / p461~461
  • Postersession 430. Activity of Glycoprotein Galactosyltransferase (GP.GT) in Serum of Cases of Ovarian Malignancy / Y. Okano et al. / p462~462
  • Postersession 431. Clinical Significance of Combination Assay with Tumor Marker in Ovarian Cancer / Y.Negishi it al / p462~462
  • Postersession 432. Basic and Clinical Studies of Tumor Marker CA15-3 in Obstetric and Gynecologic Field / S. Yamauchi et al. / p462~462
  • Postersession 433. Monitoring of Human Ovarian Carcinoma by Combination of Multiple Serum Tumor Markers / T. Kita et al. / p463~463
  • Postersession 434. Studies on Various Markers for the Precognition of the Recurrence of Ovarian Cancers / M. Nakayama et al. / p463~463
  • Postersession 435. CA19-9 and CEA in Ovarian Epithelial Tumors--Immunohistochemical Localization and Serum Levels / Y. Iwaoki et al. / p463~463
  • Postersession 436. Role of CA 125 in Patients with Ovarian Cancer--Usefulness in Periodical Monitoring / M. Kawai et al. / p464~464
  • Postersession 437. Placental Proteins 5, 10 and 11 (PP₅,₁₀ and ₁₁)--Their Serum Values during Pregnancy and Possible Clinical Application for Tumor Markers / N. Inaba et al. / p464~464
  • Postersession 438. Expression of Tumor-associated Antigens in a Case of Mixed Germ Cell Tumor / M. Hayashi et al. / p464~464
  • Postersession 439. The Distribution of LPA (Limulus Polyhemus Agglutinin) Receptors on the Cell Membrane of Peripheral Lymphocytes Associated with Cancer Patients / E. Soh (R. H. Tzeng) et al. / p465~465
  • Postersession 440. Administration Route and Timing of an Immunoactivating Agent for Ovarian Cancer / T. Noda et al. / p465~465
  • Postersession 441. The Relation between the Emesis and the Peripheral Plasma Prostaglandins during CAP Chemotherapy and Antiemetic Effect of Hydrocortisone / M. Ohwada et al. / p465~465
  • Postersession 442. Anti-cancer Effects and Side Effects Following Intraperitoneal (IP) Administration of Mitomycin C (MMC) / Y. Ino et al. / p466~466
  • Postersession 443. Mass Washing-off Therapy of Mitomycin C in the Peritoneal Cavity during the Operation of Ovarian Cancer / M. Sugase et al. / p466~466
  • Postersession 444. Not Received / /
  • Postersession 445. The Effects of Cis-Platin (CDDP) Combined Chemotherapy on Gonadal Function in Gynecological Malignancies / S. Shibata et al. / p466~466
  • Postersession 446. Intraperitoneal (Ip) High-dose-Cisplatinum (CDDP) Chemotherapy in Patients with Ovarian Cancer -Report IV Study of 33 Cases Treated with CDDP-Ip- / Y. Ninomiya et al. / p467~467
  • Postersession 447. Clinical Results of Intraperitoneal (Ip) Cisplatin (CDDP) and Systemic CAP Therapy / H. Kusanishi et al. / p467~467
  • Postersession 448. Comparative Studies of Genital Organ Tissue Concentrations, Plasma Concentrations, and Urinary Excretions of Platin between Intra-arterial and Intra-venous Injection of CDDP in Rabbits / S. Matsumoto et al. / p467~467
  • Postersession 449. Not Received / /
  • Postersession 450. The Evaluation of the Effects of Immunosuppresive Agents on Subrenal Capsule (SRC) Assay for Chemosensitivity Test / J. Haneda et al. / p468~468
  • Postersession 451. Determination of Tumor Chemosensitivity by Percentage Inhibition of DNA/Protein in Subrenal Capsule Assay / M. Nishiyama et al. / p468~468
  • Postersession 452. The Usefullness of Digital Image Processing by Computer in Subrenal Capusle Assay (SRCA) / H. Iwagaki et al. / p468~468
  • Postersession 453. Assay-Clinical Correlation in Subrenal Capsule Assay(Second Report) / T. Sasaki et al. / p469~469
  • Postersession 454. The Effects of 5-FU Derivatives on the Growth of Human Cancers Transplanted in Nude Mice / S. Imai et al. / p469~469
  • Postersession 455. The Growth Inhibitory/Cytotoxic Effects of Recombinant Human Tumor Necrosis Factor (rH-TNF) and/or Recombinant Human Interferon (rH-IFN) α, β, γ on Human Lung Cancer Cell Lines / W. S. Hong et al. / p469~469
  • Postersession 456. Intra-Arterial Long Term Infusion Chemotherapy via Transverse Cervical Artery for Intra-Abdominal Malignancies / I. Yokoyama et al. / p470~470
  • Postersession 457. Clinical Efficacy of Intra-arterial Continuous Infusion for Advanced Cancers of the Digestive System in the End Stage / H. Yamamoto et al. / p470~470
  • Postersession 458. Induced Hypertension Chemotherapy (IHC) Combined with Intraarterial Chemo-therapy for Advanced Gastric and Colorectal Carcinoma / M. Ueno et al. / p470~470
  • Postersession 459. Not Received / /
  • Postersession 460. Clinical Investigation of Transcatheter Arterial Embolization to the Patient with Recurrent and/or Advanced Pelvic Cancer / Y. Harima et al. / p471~471
  • Postersession 461. The Synergistic Effect of Human Recombinant TNF in Combination with Various Anticancer Drugs was Examined in vitro and in vivo / N. Yamauchi et al. / p471~471
  • Postersession 462. Clinical Trials (Early Phase II Study) on Malignant Human Tumors Using OH-1 Preparation Drived from BALL-1 Cell Line / S. Fuchimoto et al. / p471~471
  • Postersession 463. Cardiotoxicity of Mitoxantrone / K. Okuma et al. / p472~472
  • Postersession 464. Not Received / /
  • Postersession 465. Phase 1 Study of Carboplatin / K. Kimura et al. / p472~472
  • Postersession 466. A Case with a Carcinoma in the Lower Abdomen Treated Successfully with Oral Administration of Bestrabucil / S. Tsujitani et al. / p472~472
  • Postersession 467. A Case Report of Microangiopathic Hemolytic Anemia (MAHA) and Renal Failure after Mitomycin C and Futraful / M. Sagawa et al. / p473~473
  • Postersession 468. Assessment of the Diagnostic Value of Immunoscintigraphy with Labelled Monoclonal Antibodies (Anti CEA F (ab′)₂ and 19-9 F (ab′)₂) / T. Takahashi et al. / p473~473
  • Postersession 469. Effect of Hypoxic Cell Radiosensitizers on Murine Tumor / H. Fukuda et al. / p473~473
  • Postersession 470. Radiosencitization Using Perfluorochemicals and Angiotensin II / K. Harima et al. / p474~474
  • Postersession 471. Clinical Experience of High Dose Rate Remote Afterloading Interstitial Irradiation / K. Miura et al. / p474~474
  • Postersession 472. Ir-192 Brachytherapy by Afterloading Technique / Y. Akine et al. / p474~474
  • Postersession 473. Study on Irradiation Synchronized with Respiratory Motion / K. Ohara et al. / p475~475
  • Postersession 474. Intraoperative Radiotherapy for Cancers of the Biliary System and Pancreas / T. Yasunaga et al. / p475~475
  • Postersession 475. The Analysis of Cancer Patients Treated with Intraoperative Radiotherapy (IOR) / T. Inomata et al. / p475~475
  • Postersession 476. Tumor Cell Transplantation and Injection of Interferon as Modifying Factors of the Sensitivity of Mice to Systemic Hyperthermia / W. Nakamura et al. / p476~476
  • Postersession 477. Effect of Hyperthermia upon Mononuclear Cell Infiltration into Tumor Tissue--Analysis Using Monoclonal Antibodies / O. Kamiike et al. / p476~476
  • Postersession 478. Experimental Study of Direct Current Treatment Using Vascular Catheterization Technique(2)Usefulness of Ag-AgCl Electrode / T. Manabe et al. / p476~476
  • Postersession 479. Hyperthermia to the Patient with Adenocarcinoma / K. Yamamoto et al. / p477~477
  • Postersession 480. Local Response of Hyperthermia for Deep Seated Tumors / Y. Kajiura et al. / p477~477
  • Postersession 481. Multidisciplinary Treatment of Advanced Cancer Utilizing Local Hyperthermia,Implantable Catheter System for Intraarterial Anticancer Drug Infusion and Charcoal Hemoperfusion / T. Agishi et al. / p477~477
  • Postersession 482. Antitumor Activity of Systemically Administered Temperature-sensitive Liposomes Containing Adriamycin (TS-Lip-ADM) with Local Hyperthermia / T. Takahashi et al. / p478~478
  • Postersession 483. Clinical Trials of RF-Hyperthermotherapy for the Patients with Far-advanced Cancer of Digestive Organs / S. Sawai et al. / p478~478
  • Postersession 484. Temperature Distribution during Hyperthermia--Comparison of Calculated Values with Measured Temperatures / T. Nakajima et al. / p478~478
  • Postersession 485. Not Received / /
  • Postersession 486. Total Body Hyperthermia against advanced Cancer with Peritoneal Metastasis / N. Kato et al. / p479~479
  • Postersession 487. Antiproliferative Effect of Interferon and Hyperthermia / T. Satoh et al. / p479~479
  • Postersession 488. Not Received / /
  • Postersession 489. Multidisciplinary Treatment with Combined Hyperthermia, Radiation and Chemother-apy--Analysis of Prognostic Factors, and Predicted Prognoses by Multivariate Analysis / M. Endow et al. / p479~479
  • Postersession 490. Clinical Evaluation of Total-Body Hyperthermia Combined with Anticancer Chemo-therapy for Far-Advanced Miscellaneous Cancer in Japan / M. Maeta et al. / p480~480
  • Postersession 491. Neutralization Test with Clonogenic Assay / K. Okamoto et al. / p480~480
  • Postersession 492. Combination Chemotherapy Evaluated by Human Tumor-Clonogenic Assay / K. Suzuki et al. / p480~480
  • Postersession 493. Comparative Study of Antitumor Activity and Myelosuppression of Three Platinum Complexes by HTCA and CFU-c Assay / H. Takahashi et al. / p481~481
  • Postersession 494. Clinical Utility of the Scintillation Assay / N. Tanigawa et al. / p481~481
  • Postersession 495. In vitro Chemosensitivity of Various Human Tumors Evaluated by Succinate Dehy-drogenase Inhibition (SDI) Test / Y. Maehara et al. / p481~481
  • Postersession 496. Significance of the Measurement of Serum and Urinary /β₂-Microglobulin in Cancer Chemotherapy / E. Araki et al. / p482~482
  • Postersession 497. Fundamental Research about Application of Pulsing Magnetic Field to the Cancer Therapy / Y. Omote et al. / p482~482
  • Postersession 498. Cancer Chemotherapy with Oriental Medicine / A. Sato et al. / p482~482
  • Postersession 499. Effect of UFT, FT and PSK on Immunological Competent Cells / S. Nakao et al. / p483~483
  • Postersession 500. The Effect of OK-432 to the Intratumor 5-FU Concentration after UFT Administration / Y. Yamamoto et al. / p483~483
  • Postersession 501. Clinical Study on UFT.MMC Combination Chemotherapy for Cancer of Digestive Organ / S. Orii et al. / p483~483
  • Postersession 502. Concentration and Enzyme Activity in the Tissues of Patients on Oral Administration of 5-FU Derivative (5′-DFUR) / T. Ohno et al. / p484~484
  • Postersession 503. Not Received / /
  • Postersession 504. Effects of High-dose 5FU (or FT-207) Therapy Combined with Intravenous Hyper-alimentation for the Recurrent Retroperitoneal Malignancies of Alimentary Tract / H. Nagano et al. / p484~484
  • Postersession 505. Clinical Pharmacokinetics of Cisplatin / T. Ohno et al. / p484~484
  • Postersession 506. Renal Dysfunction in Mice Cured of Ascites Tumor by the Use of Large Dose of CDDP / K. Komatsu et al. / p485~485
  • Postersession 507. Improved Control of Cisplatin-induced Emesis with Combination of Moderated Dose Metoclopramide, Dexamethasone, Droperidol, and Diphenhydramine / K. Iwamoto et al. / p485~485
  • Postersession 508. Anticancer Efficacy of Cis-Platinum Administered by Intracavitary Injection / K. Kikuchi et al. / p485~485
  • Postersession 509. As Density Shift of Cisplatin and CQ in the Ascites of Peritonitis Carcinomatosa / T. Oda et al. / p486~486
  • Postersession 510. Cisplatin in the Treatment of Advanced Cancer of GI Tract / H. Kitagawa et al. / p486~486
  • Postersession 511. Early Phase II Study of Cisplatin in Gastric and Colon Cancer / K. Ishibiki et al. / p486~486
  • Postersession 512. Cisplatin-Based Combination Chemotherapy in the Treatment of Patients with Malignancy--Regimen, Prevention of Side Effect and Combination of Immunotherapy / K. Yamada et al. / p487~487
  • Postersession 513.Clinical Evaluation of Serum Sialosyl SSEA-1 Antigen as a Tumor Marker / Y.Ariyoshi et al. / p487~487
  • Postersession 514.Effects of Radiotherapy on Lymphocyte Subsets in Patients with Lung Cancer A Preliminary Result of Two Color Analysis Using Fluorescence-labeled Monoclonal Antibodies / S.Nakatsugawa et al. / p487~487
  • Postersession 515.Radiotherapy for Stage III Non-Small Cell Carcinoma of the Lung / J.Watarai et al. / p488~488
  • Postersession 516.Suitable Radiation Dose in Radical Radiotherapy for Lung Cancer / N.Nakajima et al. / p488~488
  • Postersession 517.Randomized Prospective Study of Radiation versus Radiation plus ACNU in Non-Small-Cell Lung Cancer / S.Hashimoto et al. / p488~488
  • Postersession 518.The Changes of Electrophoretic Mobility Pattern and OKT8/OKT4 Ratio in Periph-eral Blood Lymphocytes of the Lung Cancer Patients / Y.Nishimura et al. / p489~489
  • Postersession 519.Synergistic Antitumor Effects of OH-1 H-7-1 Fraction(Natural-human TNF)and Mouse Interferon Beta on Lewis Lung Carcinoma / S.Itano et al. / p489~489
  • Postersession 520.A Phase I/II Study of Recombinant Interleukin 2 (rIL-2) / T.Sano et al. / p489~489
  • Postersession 521.Bromodeoxyuridine(BrdU)Labeling Method for the Study of Cancer Cell Cycle Analysis / T.Fujikane et al. / p490~490
  • Postersession 522.In vitro Chemosensitivity Test:Mini-scintillation Assay(Mini-hybrid Assay)Using Double Soft Agar Method / H.Nakano et al. / p490~490
  • Postersession 523.Subrenal Capsule Assay in Human Lung Cancer / S.Kudoh et al. / p490~490
  • Postersession 524.Evaluation of the Combination Chemotherapy Including Cis-platinum by the Checker Board Analysis / K.Lee et al. / p491~491
  • Postersession 525.Experimental and Clinical Study of Intrapleural Administration of CDDP and Ara-C for Malignant Pleural Effusion / K.Yonezawa et al. / p491~491
  • Postersession 526.A Randomized Comparison between CDDP+ADR+CPA and CDDP+PLM+VP16 in Extensive Non-Small Cell Lung Cancer / S.Yoneda et al. / p491~491
  • Postersession 527.Cisplatin(CDDP),Adriamycin(ADR)and VP-16
  • (CAV)in the Treatment of Small Cell(SCLC)and Non-small Cell(NSCLC)Lung Cancer / Y.Yamaji et al. / p492~492
  • Postersession 528.Experimental Studies on the Concentration of 5-Fluorouracil in Various Tissues Following Nebulization Chemotherapy / S.Koyama et al. / p492~492
  • Postersession 529.A Phase II Study of UFT for Non-small Cell Lung Cancer / E.Shimizu et al. / p492~492
  • Postersession 530.A Newly Designed Sustained Release Anti-cancer Chemotherapy with Use of Silicone / K.Matsumura et al. / p493~493
  • Postersession 531.The Results of Multidisciplinary Treatment for Non-small Cell Lung Cancer(NSCLC) / M.Murakarmi et al. / p493~493
  • Postersession 532.Photodynamic Therapy for Severe Metaplasia of the Lung / K.Yoneyama et al. / p493~493
  • Postersession 533.Panpleuropneumonectomy for Carcinomatous Pleuritis due to Lung Cancer / T.Sakai et al. / p494~494
  • Postersession 534.The "Quality of Life"of Patients with Lung Cancer / S.Negoro et al. / p494~494
  • Postersession 535.A Study of Double Cancer Involving Lung and Other Organs / Y.Uchiyama et al. / p494~494
  • Postersession 536.Classification and Treatment of Anterior Mediastinal Germ Cell Tumors / M.Irako et al. / p495~495
  • Postersession 537.Clinical Evaluation of Primary Pulmonary Malignant Lymphoma / Y.Matsuzaki et al. / p495~495
  • Postersession 538.Basic and Clinical Studies on Adoptive Immunotherapy(AIT)with LAK Cells / H.Suzuki et al. / p495~495
  • Postersession 539.Comparative Data on Cytophotometric DNA in Malignant Lesions of the Esophagus in the Chinese and Japanese / Y.Koga et al. / p496~496
  • Postersession 540.Evaluation of Tumor-markers in the Serum of Patients with Carcinoma of the Esophagus / T.Kawaguchi et al. / p496~496
  • Postersession 541.The Serum Squamous Cell Carcinoma Antigen(SCC)Level of the Esophageal Squamous Cell Carcinoma / K.Ikeda et al. / p496~496
  • Postersession 542.Efficacy of MRI in Detection of the Extent of Advanced Esophageal Cancer / H.Kubo et al. / p497~497
  • Postersession 543.Low Dose Rate Teletherapy as Boost Therapy for Esophageal Carcinoma / S.Yamada et al. / p497~497
  • Postersession 544.The Role of Radiation Therapy in the Surgical Treatment of Cancer of the Esophagus / A.Okazaki et al. / p497~497
  • Postersession 545.Effect of Tumor Bearing,Aging and Malnutrition on the Augmentation of Murine Splenic NK Activity by in vivo Treatment with OK-442 / K.Shimoda et al. / p498~498
  • Postersession 546.Efficacy of Subrenal Capsule Assay for Esophageal Cancer / H.Fukui et al. / p498~498
  • Postersession 547.Subrenal Capsule Assay for Esophageal Cancer / M.Terashima et al. / p498~498
  • Postersession 548.CDDP Administration for the Treatment of Advanced Esophageal Cancer / T.Shimokawa et al. / p499~499
  • Postersession 549.A Study of Preoperative Administration of CDDP in 10 Cases of Esophageal Carcinoma / H.Shimizu et al. / p499~499
  • Postersession 550.Serum Levels and Organ Distribution of Platinum Following Administration of CDDP in the Esophageal Cancer / S.Shiraha et al. / p499~499
  • Postersession 551.Multimodality Treatment Combined with Radiotherapy and Chemotherapy for Inoper-able and Postoperative Recurrent Carcinoma of the Esophagus / M.Shinoda et al. / p500~500
  • Postersession 552.Combination of Polychemotherapy and Radiation for Esophageal Cancer / H.Inaba et al. / p500~500
  • Postersession 553.Clinical Study of Preoperative Chemotherapy for Advanced Esophageal Cancer / K.Namatame et al. / p500~500
  • Postersession 554.Experimental Study of Thermochemotherapy for Human Esophageal Carcinoma Cells / M.Saitoh et al. / p501~501
  • Postersession 555.Effects of Pre-Operative Hyperthermia alone for Patients with Esophageal Cancer / T.Ohmori et al. / p501~501
  • Postersession 556.Local Hyperthermia by Endoradiotherm 100A Combined with Polychemotherapy in Esophageal Cancer / Y.Yamashita et al. / p501~501
  • Postersession 557.Effects of Hyperthermo-Chemo-Radiotherapy on KSE-1,a Newly Established Human Squamous Cell Line Derived from Esophageal Carcinoma / H.Matsuoka et al. / p502~502
  • Postersession 558.Evaluations on Thermo Methods with RF Wave Inner Electrode against Carcinoma of the Esophagus / K.Higashino et al. / p502~502
  • Postersession 559.Cell Kinetic Reactions of Human Esophageal Cancer Cells in vitro(SGF-5)Following Administration of Anticancer Agents or Hyperthermia:Analysis by FCM Using Anti-BrdUrd Monoclonal Antibody / S.Munakata et al. / p502~502
  • Postersession 560.Not Received / /
  • Postersession 561.Resection versus Irradiation in the Treatment of Dysphagia in Esophageal Carcinoma / R.Kirchner et al. / p503~503
  • Postersession 562.Clinical Evaluation of Pancreas Tissue Antigen(PaA) / J.Furukawa et al. / p503~503
  • Postersession 563.Relation of Tumor Markers(CEA,CA19-9)and Glycosylated Hemoglobin(HbA₁)in Diabetic Patients / T.Kurihara et al. / p503~503
  • Postersession 564.The Study of the Tumor Marker in the Malignany of Liver,Bile Duct and Pancreas / T.Makino et al. / p504~504
  • Postersession 565.Production and Characterization of Monoclonal Antibodies,FP-1,FP-2 and FP-3,against Human Fetal Pancreas / K.Shibata et al. / p504~504
  • Postersession 566.Not Received / /
  • Postersession 567.A Role of Radiation Therapy in the Treatment of Pancreatic Cancer / T.Ogino et al. / p504~504
  • Postersession 568.A Trial of Intraoperarive Administration of Neocarzinostatin in Subserosal of Duode-num for Pancreatoduodenal Cancer / Y.Hase et al. / p505~505
  • Postersession 569.In vivo Induction of Lymphokine-activated Killer(LAK)Cells by Infusion of Interleu-kin 2(IL-2)into the Splenic Artery / H.Takagi et al. / p505~505
  • Postersession 570.Combined Modalitytherapy of the Pancreatic Cancer (Mainly Hyperthermia) / S.Akaishi et al. / p505~505
  • Postersession 571.Acute Suppurative Cholangitis due to Carcinoma of Pancreas and Biliary Truct / A.Yamaguchi et al. / p506~506
  • Postersession 572.Clinical Significance of Bile Carcinoembryonic Antigen(CEA)and Bile Carbohydrate Antigen(CA19-9)in Biliary Disease / K.Odani et al. / p506~506
  • Postersession 573.Measurement of PIVKA-II on HCC Using E-1023 / R.Ohmizo et al. / p506~506
  • Postersession 574.Clinical Evaluation of MRI for Hepatoma / T.Kato et al. / p507~507
  • Postersession 575.A Study on Cases Having Undergone Early Angiography and TAE Therapy after Hepatectomy / Y.Hiraide et al. / p507~507
  • Postersession 576.The Evaluation of Intrahepatic Recurrence of Resected Hepatocellular Carcinoma / H.Nishio et al. / p507~507
  • Postersession 577.The Significance of Pre-operative TAE for the Patients with HCC / S.Imaoka et al. / p508~508
  • Postersession 578.Not Received / /
  • Postersession 579.Treatment and Survival Rate of Hepatocellularcarcinoma / H.Sakai et al. / p508~508
  • Postersession 580.Studies on the Surgical Treatment and Chemotherapy of Liver Metastases / I.Mizuno et al. / p508~508
  • Postersession 581.Radiation Therapy of Biliary Duct Malignant Tumor / K.Nakagawa et al. / p509~509
  • Postersession 582.The Role of Radiation Therapy in the Management of Biliary Tract Tumor / T.Kamada et al. / p509~509
  • Postersession 583.Effects of Anticancer Drugs on Hepatic Fibrosis in Rats with Carbon Tetrachloride Induced Hepatic Dysfunction / J.Ono et al. / p509~509
  • Postersession 584.The Effect of Etoposide(Et)on Primary Hepatocellular Carcinoma(HCC) / N.Tanaka et al. / p510~510
  • Postersession 585.FT,5FU,and Uracil Concentration in Blood,Bile,and Tissue of Hepatoma with Liver Cirrhosis after Oral Administration of UFT / S.Oguma et al. / p510~510
  • Postersession 586.Clinical Studies of UFT for Hepatocellular Carcinoma / G.Yamaguchi et al. / p510~510
  • Postersession 587.Chemotherapy for Hepatocellular Carcinoma / H.Nasu et al. / p511~511
  • Postersession 588.Phase II Study of Intravenous Mitoxantrone in Patients with Advanced Hepatocellular Carcinoma / T.Yoshida et al. / p511~511
  • Postersession 589.Clinical Study on Cisplatin in the Treatment of Hepatocellular Carcinoma / K.Mitsuyama et al. / p511~511
  • Postersession 590.Chemotherapy of Nonresectable Liver Carcinoma by Portal Infusions Using Subcuta-neous Portal Reservoir(SCPR) / K.Akimaru et al. / p512~512
  • Postersession 591.Experimental Study on Cryo-chemotherapy / T.Morita et al. / p512~512
  • Postersession 592.The Features of Liver Metastasis of Breast Cancer on Imaging and Its Response to Arterial Infusion Chemotherapy / T.Kakuta et al. / p512~512
  • Postersession 593.Clinical Evaluation of Local Infusion Chemotherapy for Metastatic Liver Carcinoma Using Port-A-Cath--Determination of Chemotherapeutic Agents by Subrenal Capsule Assay / E.Yokoyama et al. / p513~513
  • Postersession 594.Intrahepatic Arterial Infusion Chemotherapy for the Unresectable Malignant Tumors of Liver Using Implantable Infusion Pump / Y.Tsuji et al. / p513~513
  • Postersession 595.Transcatheter Chemo-Embolization Using Adriamycin for Unresectable Hepatocel-lular Carcinoma:Therapeutic Evaluation by Comparison with Intra-Arterial One Shot Injection of Adriamycin / M.Itsubo et al. / p513~513
  • Postersession 596.Effective Chemotherapy for Primary or Metastatic Malignant Liver Tumor with Intra-Hepato-Arterial Infusions of Cis-Diamminedichloroplatinum(II)plus 5 Fluorour-acil / T.Wakatsuki et al. / p514~514
  • Postersession 597.A New Approach to Chemoembolization Therapy for Hepatoma Using Ethiodized Oil,Cisplatin and Gelatin Sponge (Sandwitch Therapy) / Y.Sasaki et al. / p514~514
  • Postersession 598.Arterial Embolization of Liver Malignancies with FudR-Lipiodol / Y.Yamashita et al. / p514~514
  • Postersession 599.Clinical Evaluation of Transcatheter Chemoembolization for Malignant Hepatic Tumors with Degradable Starch Microspheres / K.Itani et al. / p515~515
  • Postersession 600.A Review of Predictable Factors in the Cases of Serious Complications within One Month after TAE for Hepatocellular Carcinoma / S.Nakatsuka et al. / p515~515
  • Postersession 601.The Effects of Arterial Chemoembolization with Degradable Starch Microspheres Combined with Hyperthermia in the Treatment of Liver Tumors / T.Murata et al. / p515~515
  • Postersession 602.Local Radiofrequency(RE)Hyperthermia for Metastatic Liver Tumor / S.Takegawa et al. / p516~516
  • Postersession 603.Not Received / /
  • Postersession 604.Multidisciplinary Treatment for Advanced or Recurrent Liver Cancer Using Micro-wave Tissue Coagulator(The 2nd Report) / H.Kodama et al. / p516~516
  • Postersession 605.Phase II Study γ-Interferon(INF-γ)for Hepatocellular Carcinoma(HCC) / M.Yoshino et al. / p516~516
  • Postersession 606.Anticancer Effects of a Lipophilic Prodrug of 5-fluoro-2′-deoxyuridine(FUdR) Dissolved in an Oily Lymphographic Agent(Lipiodol Ultra-Fluid) on Hepatic Cancer by Injection into Hepatic Artery / S.Fukushima et al. / p517~517
  • Postersession 607.Effects of Ethanol Injection Therapy on Hepatocellular Carcinoma / A.Furusawa et al. / p517~517
  • Postersession 608.A Case Report of Fibrolamellar Carcinoma of the Liver with Bile Duct Invasion / H.Taniura et al. / p517~517
  • Postersession 609.New Multimodality Therapy on Malignant Tumors of Biliary Tract / M.Mukai et al. / p518~518
  • Postersession 610.Preoperative Therapy of Bladder Cancer / T.Nasu et al. / p518~518
  • Postersession 611.Preoperative Thermoradiotherapy for Invasive Bladder Cancer / K.Akuta et al. / p518~518
  • Postersession 612.The Role of Pre-operative Intra-arterial Doxorubicin Chemotherapy in Combination with Low-dose Irradiation for Bladder Cancer / H.Yokozeki et al. / p519~519
  • Postersession 613.Conservative Treatment with RF Hyperthermia for Bladder Cancer / R.Noguchi et al. / p519~519
  • Postersession 614.Histological Study and Analysis of Blood and Tissue CDDP Concentration Value after Intra Arterial Infusion Therapy for Bladder Cancer / Y.Aota et al. / p519~519
  • Postersession 615.NK Cell Activity of Urologic Cancer Patients after Chemoembolization / R.Abe et al. / p520~520
  • Postersession 616.Monoclonal Antibodies to Human Bladder Cancer Cells(The Third Report) / N.Takahashi et al. / p520~520
  • Postersession 617.MVP-CAB Regimen for Advanced Transitional Cell Carcinoma of the Urinary Tract / S.Den et al. / p520~520
  • Postersession 618.Percutaneous Treatment for Renal Pelvic Tumor / M.Yanagawa et al. / p521~521
  • Postersession 619.Photodynamic Therapy for Superficial Bladder Tumors / T.Misaki et al. / p521~521
  • Postersession 620.Whole Bladder Wall Photodynamic Therapy Using a Newly Designed Light-scattering Device for Superficial Multicentric Bladder Tumors with/without Carcinoma in Situ of the Bladder / T.Uchibayashi et al. / p521~521
  • Postersession 621.Combination Therapy of Microwave Coagulation and Intracavitary Irradiation for Bladder Cancer / T.Harada et al. / p522~522
  • Postersession 622.Clinicopathological Analysis of Patients with Bladder Tumor Treated by Partial Cystectomy / H.Takada et al. / p522~522
  • Postersession 623.New En Bloc Radical Cystectomy for Invasive Bladder Carcinoma / Y.Hiraoka et al. / p522~522
  • Postersession 624.Criteria of the Prophylactic Urethrectomy in Male Patients Undergoing Radical Cystectomy for Bladder Carcinoma / K.Hasuo et al. / p523~523
  • Postersession 625.The Quality of Life in Male Patients with Bladder Cancer after Total Cystectomy with Ileal Conduit:Results of Questionnaire Surveys to Compare the Impact of Treatments / M.Miyakawa et al. / p523~523
  • Postersession 626.Urethral Recurrence of Bladder Cancer Following Cystectomy / H.Kakizaki et al. / p523~523
  • Postersession 627.Histopathological Prognosticating Features after Radical Cystectomy / N.Sakakibara et al. / p524~524
  • Postersession 628.Continent Urinary Reservoir for Bladder Carcinoma / N.Honda et al. / p524~524
  • Postersession 629.Bladder Cancer:Factors Affecting Survival / K.Miyamoto et al. / p524~524
  • Postersession 630.Prophylactic Intravesical Instillation Chemotherapy for Post-operating Superficial Bladder Cancer / Z.Kataumi et al. / p525~525
  • Postersession 631.Intravesical Etopic Recurrence of Bladder Tumors / S.Iwamuro et al. / p525~525
  • Postersession 632.Treatments and Actual Status of Bladder Cancer in Elderly Patients / I.Hirano et al. / p525~525
  • Postersession 633.Two Cases of Squamous Cell Carcinoma of the Bladder / K.Kumagai et al. / p526~526
  • Postersession 634.Secondary Foci of Primary Tumors of the Bladder in the Upper Urinary Tract:Report of 4 Cases / T.Mishina et al. / p526~526
  • Postersession 635.Surface Marker Analysis of Solid Tumor Cells / K.Tabuchi et al. / p526~526
  • Postersession 636.Measurement of Blood NCC-ST-439 Antigen by Enzyme Immunoassay Kit(EIA Kit) and Evaluation of It as a Tumor Marker / E.Hanada et al. / p527~527
  • Postersession 637.Combined Antitumor Effect of MMC and Polyl:C against Murine Tumor Implanted in Mice / M.Sakurai et al. / p527~527
  • Postersession 638.Effect of TCA Therapy on Host Parameter (Basic Investigation) / K.Orimo et al. / p527~527
  • Postersession 639.An Immunological Cancer Therapy Trial Sensitized by Tumor Cell Derived Carbo-hydrate Antigen(TCA) / Y.Suzuki et al. / p528~528
  • Postersession 640.Effect of TCA Therapy on Host Parameter (Clinical Investigation) / K.Ietomi et al. / p528~528
  • Postersession 641.Experimental Studies of Adoptive Immunotherapies with Activated Cells by Inter-feron,Interleukin-2 and OK-432 on Human Gastric Cancers SC-6 and H-111 Xeno-graft in Nude Mice / M.Yamaguchi et al. / p528~528
  • Postersession 642.IFN-γ Production in Human Peripheral Mononuclear Cells in Response to PHA and K562 Cells / R.Izutani et al. / p529~529
  • Postersession 643.Not Received / /
  • Postersession 644.Lymphocyte Functions in the Patients with Cancer / S.Yamaga et al. / p529~529
  • Postersession 645.Suppressor Cell Activity against Natural Killer Cell Activity in Cancer Patients / E.Yanagawa et al. / p529~529
  • Postersession 646.Combination Chemoimmunotherapy of Advanced Cancer with MMC and OK432 / S.Arinaga et al. / p530~530
  • Postersession 647.Studies on Adoptive Immunotherapy with Lymphokine Activated Killer(LAK)Cell for Clinical Use / N.Terata et al. / p530~530
  • Postersession 648.Experimental Study on Adoptive Immunotherapy Using LAK Cells--Anti-tumor Activities of LAK Cellsin in vitro and in vivo Assays / H.Takao et al. / p530~530
  • Postersession 649.Clinical Efficacy of Systemic and Local Transfer of LAK Cells (Pilot Study) / S.Nojiri et al. / p531~531
  • Postersession 650.A Study Concerning the Practical Use of LAK Cells / M.Ohta et al. / p531~531
  • Postersession 651.Adoptive Immunotherapy for Advanced Cancer Patients with Lymphokine Activated Killer Cells / H.Yamada et al. / p531~531
  • Postersession 652.Pre-and Post-operative Changes in Killer Activity of Peripheral Blood Lymphocytes and LAK Cells of Gastric and Colonic Cancer Patients / S.Tachibana et al. / p532~532
  • Postersession 653.The Antitumor Effects and the Mechanisms of Bacterial Endotoxin(LPS) / M.Horisawa et al. / p532~532
  • Postersession 654.The Statistical Analysis of Advanced Cancer Patients in Treatment with an Extract from Human Tubercle Bacilli(S.S.M.) -Report VIII / K.Fujita et al. / p532~532
  • Postersession 655.OK432-induced Production of IFN-γ in Peripheral Mononuclear Cells from Healthy Subjects and Patients with Cancer / H.Matsumoto et al. / p533~533
  • Postersession 656.Evaluation of the Repeated Local admlinistration of OK432 against Malignancies / M.Ochiai et al. / p533~533
  • Postersession 657.Role of Impaired NK Cell and Macrophage Activities in Enhancement of Tumor Metastasis and Its Prevention by OK-432 Administration--Experimental Study in a Rat Metastatic Lung Tumor Model / H.Kida et al. / p533~533
  • Postersession 658.Intracavitary Injection of OK-432 with Fresh Frozen Plasma against Carcinomatous Peritonitis and Pleuritis--Arachidonate Metabolites and Chemotaxisis / H.Kato et al. / p534~534
  • Postersession 659.Induction of Activated Natural Killer Cells from Murine Spleen Cells Primed in vivo and Subsequently Challenged in vitro with Streptococcal Preparation OK432 / H.Yamaue et al. / p534~534
  • Postersession 660.Clinical Analysis of Killer Cell Augmentation in Digestive Organ Cancer Patients Treated with OK432 / M.Zeniya et al. / p534~534
  • Postersession 661.Effect of Hyperthermia on the Antiproliferative Activities of Human Interferons and Antineoplastics / K.Yoneda et al. / p535~535
  • Postersession 662.In vivo Antiproliferative Effect of Recombinant Human Interferons,Alone and in Combination / Y.Naomoto et al. / p535~535
  • Postersession 663.Combined Effect of Human Recombinant Interferon-γ and Adriamycin on Experi-mental Pulmonary Metastasis in Nude Mice / H.Kondo et al. / p535~535
  • Postersession 664.In vitro Enhancement of Cytotoxicity of Human Peripheral Blood Lymphocytes with Recombinant Interleukin 2 and Interferon Mixture(α+β+γ)against Human Colon Carcinoma Cell Line SW1116 / Y.Kimoto et al. / p536~536
  • Postersession 665.Regulation of Prostaglandin E₂ and Interleukin-1 Production of Cancer Patients by BRM Theraphy / R.Asai et al. / p536~536
  • Postersession 666.Phase I and Early Phase II Studies of PT-050 (Recombinant Human Tumor Necrosis Factor:rHu-TNF) / T.Taguchi et al. / p536~536
  • Postersession 667.Anti Tumor Therapy to Metastatic Colon Carcinoma in Liver by Induction of Endogenous Tumor Necrosis Factor / K.Takagi et al. / p537~537
  • Postersession 668.Anti-tumor Therapy for Metastatic Urological Cancer by Induction of Endogenous TNF / M.Kato et al. / p537~537
  • Postersession 669.Anti-tumor Therapy by Induction of Endogenous Tumor Necrosis Factor(TNF)in Gynecologic Cancer / K.Dobashi et al. / p537~537
  • Postersession 670.Immunological Responsiveness under Immune-surveillance Therapy against Terminal Cancer of Digestive Organs / I.Sato et al. / p538~538
  • Postersession 671.Role of Serum Factors in Impairment of Host Immunocompetence during the Early Post-cryosurgical Period--Experimental Study / H.Niwa et al. / p538~538
  • Postersession 672.Not Received / /

「国立国会図書館デジタルコレクション(雑誌)」より

この本の情報

書名 日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
著作者等 日本癌治療学会
書名ヨミ ニホン ガン チリョウ ガッカイシ = The journal of Japan Society of Clinical Oncology
書名別名 The journal of Japan Society for Cancer Therapy

日本癌治療学会学術集会educational book

日本癌治療学会学術集会プログラム号

日本癌治療学会学術集会抄録号

The journal of Japan Society of Clinical Oncology
巻冊次 22(2)
出版元 日本癌治療学会
刊行年月 1987-03
ページ数
大きさ 25-30cm
ISSN 00214671
NCID AN00187361
※クリックでCiNii Booksを表示
全国書誌番号
00018418
※クリックで国立国会図書館サーチを表示
言語 英語
日本語
出版国 日本
この本を: 
このエントリーをはてなブックマークに追加

Yahoo!ブックマークに登録
この記事をクリップ!
Clip to Evernote
このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想